Page last updated: 2024-08-21

lactulose and Encephalopathy, Hepatic

lactulose has been researched along with Encephalopathy, Hepatic in 413 studies

Research

Studies (413)

Timeframe	Studies, this research(%)	All Research%
pre-1990	98 (23.73)	18.7374
1990's	50 (12.11)	18.2507
2000's	53 (12.83)	29.6817
2010's	148 (35.84)	24.3611
2020's	64 (15.50)	2.80

Authors

Authors	Studies
Choudhuri, G; Goswami, BD; Kalita, P; Kapoor, D; Khaleeq, A; Nijhawan, S; Patil, S; Shah, R	1
Chen, Q; Huang, J; Li, M; Shui, D; Zhang, Z; Zhou, X	1
Dalal, A; Jain, A; Kumar, A; Mahajan, B; Sachdeva, S; Sharma, BC; Sonika, U; Srivastava, S	1
Cao, W; Chen, Y; Cheng, J; Zuo, G	1
Bashaw, L; Grzyb, K; Louissaint, J; Mohammad, RA; Parikh, ND; Tapper, EB	1
Giri, S	1
Gibbs, JT; Louissaint, J; Tapper, EB	1
Ridola, L; Riggio, O	1
Jalan, R; Rose, CF	1
Essien, UR; Parikh, ND; Tapper, EB; Ufere, NN; Zhao, Z	1
Fu, J; Gao, Y; Shi, L	1
Gentene, AJ; Guido, M; Pence, A; Stoll, AM	1
Bajaj, JS; Hassanein, TI; Heimanson, Z; Israel, RJ; Pyrsopoulos, NT; Rahimi, RS; Rockey, DC; Sanyal, AJ	1
Bajaj, JS; Beyers, L; Shaw, J	1
Hayakawa, Y; Higuchi, M; Inada, K; Ishido, S; Izumi, N; Kakegawa, T; Kaneko, S; Kirino, S; Kurosaki, M; Maeyashiki, C; Matsumoto, H; Nakanishi, H; Nobusawa, T; Okamoto, R; Takahashi, Y; Takaura, K; Tamaki, N; Tanaka, S; Tanaka, Y; Tsuchiya, K; Yamashita, K; Yasui, Y	1
Atkins, AR; Downes, M; Evans, RM; Huan, T; Loomba, R; Madamba, E; Oh, TG; Sharpton, SR; Wang, C; Yu, RT	1
Chen, W; Feng, X; Jiang, Z; Li, X; Pan, H; Tian, Y; Yang, Q; Yang, Y; Zhang, X	1
Dugan, AJ; Fritz, MK; Hunt, TV; Karri, K; Mangino, AA; Pitcock, CT; Yarra, P	1
Barritt, AS; Bissram, JS; Jiang, Y; Kim, HP; Lupu, G; Moon, AM; Tapper, EB	1
Faccioli, J; Gioia, S; Nardelli, S; Ridola, L; Riggio, O	2
Balzano, T	1
Badal, BD; Bajaj, JS	1
Ahmed, Z; Arif, SF; Aziz, M; Badal, J; Farooq, U; Hassan, M; Iqbal, U; Javaid, T; Nawaz, A; Nawras, A; Renno, A; Saab, S; Smith, WL	1
Djernes, L; Eriksen, PL; Ott, P; Vilstrup, H	1
Chen, X; Nikirk, S; Ospina, E; Salim, N; Tapper, EB	1
Chen, KT; Chow, KW; Dang, A; Dang, L; Ibrahim, BM; Jackson, NJ; Saab, S; Yum, JJ	1
Parikh, ND; Tapper, EB	1
Li, F; Shi, J	1
Amodio, P; Shawcross, DL; Thabut, D	1
Fortune, BE; Jesudian, AB	1
Anderson, BM; Lewis, DJ; Swansson, WD; Yeoh, SW	1
Almaghrabi, M; Brar, S; Khan, MQ; Liang, A; Qumosani, K; Teriaky, A	1
Bloom, PP; Tapper, EB	1
Adler, E; Aronsohn, AI; Beavis, KG; Boissiere, J; Cantoral, J; Charlton, MR; Cole, CG; Cotter, TG; Dela Cruz, M; Dylla, NP; Haro, F; Hutchison, AL; Khalid, M; Lehmann, C; Light, SH; Lin, H; Moran, A; Mostad, JD; Odenwald, MA; Oliveira, RA; Pamer, EG; Pappas, TE; Paul, S; Pillai, A; Ramaswamy, R; Reddy, KG; Rinella, ME; Sidebottom, AM; Stutz, MR; Sundararajan, A; Te, HS; Waligurski, E	1
Bajaj, JS; Fagan, A; Nadeem, M; Park, D; Tafader, A; Wade, JB	1
Brandt, LJ; Feuerstadt, P; Hong, SJ	1
Bajaj, JS; Guo, XL; Jiang, HX; Meng, LN; Mi, YQ; Shang, J; Wang, BS; Wang, JB; Wang, JY; Xu, JM; Yang, JH; Zhang, NP; Zhou, XM; Zhu, X	1
Chopra, M; Dhiman, RK; Duseja, A; Dutta, U; Rathi, S; Singal, AK; Singh, M; Taneja, S; Thumburu, KK; Verma, N	1
Campbell, SM; Clements, DN; Ferreira, MDF; Gaylor, DE; Gow, AG; Mellanby, RJ; Salavati Schmitz, S; Salavati, M; Schoenebeck, JJ	1
Boutros, S; Saab, S; Winters, A; Yanny, B	1
Haj, M; Rockey, DC	1
Baki, J; Korovaichuk, S; Nikirk, S; Parikh, ND; Tapper, EB; Waljee, AK; Williams, S	1
Adarkwah, CC; Buggisch, P; Frieling, T; Galle, PR; Hofmann, WP; Labenz, C; Labenz, J; Miehlke, S; Wörns, MA	1
Eder, MD; Hosseini, R; Kravetz, JD; Thomas, A; Varma, P	1
Bryce, K; Marelli, L; Ruban, A; Tern, PJW	1
Mahpour, NY; Pioppo-Phelan, L; Reja, M; Rustgi, VK; Tawadros, A	1
Elsaid, MI; John, T; Li, Y; Pentakota, SR; Rustgi, VK	1
Phelan, LP; Reja, M; Rustgi, VK; Senatore, F	1
Abughosh, SM; Chen, H; Serna, O; Vadhariya, A; Zamil, H	1
Kamimura, H; Kamimura, K; Sakamaki, A; Takamura, M; Terai, S; Yamazaki, F; Yokoyama, J; Yokoyama, K	1
Ahmad, M; Bozkaya, D; Jesudian, AB; Migliaccio-Walle, K	1
Bohra, A; Farrell, A; Hui, S; Robertson, M; Terbah, R; Worland, T	1
Bajaj, JS; Fagan, A; Fuchs, M; Gavis, EA; Gillevet, PM; Heuman, DM; Hu, C; Iyer, MV; Iyer, RK; Saboo, K; Shamsaddini, A; Sikaroodi, M; White, MB	1
Burnham, K; Reinert, JP	1
Anjur, V; Bajaj, JS; Biggins, SW; Fallon, MB; Garcia-Tsao, G; Hu, C; Iyer, RK; Kamath, PS; Lai, JC; Maliakkal, B; O'Leary, J; Reddy, KR; Saboo, K; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, P; Vargas, H; Wong, F	1
Ahmed, S; Dhiman, RK; Duseja, A; Imran, R; Kaur, P; Kulkarni, AV; Mehtani, R; Mishra, S; Premkumar, M; Roy, A; Singh, V; Taneja, S	1
Bajaj, JS; Bhamidimarri, KR; Bukofzer, S; Potthoff, A; Pyrsopoulos, N; Rahimi, RS; Safadi, R; Thabut, D	1
Beuers, UHW; Coenen, S; Coenraad, MJ; Cuperus, FJC; de Wit, K; Dijkgraaf, MGW; Kramer, M; Mostafavi, N; Nevens, F; Schaapman, JJ; Takkenberg, RB; Tjwa, ETTL; van Delden, OM; Verbeek, J	1
Abu-Zaid, A; Adhami, T; Ayas, MF; Durer, C; Durer, S; Hoilat, GJ; Hoilat, JN; John, S	1
Chauhan, A; Sharma, S	1
Akarapatima, K; Chang, A; Chaojin, T; Piratvisuth, T; Rattanasupar, A	1
López-Sánchez, M; Milke-García, MDP; Moran, S; Rodríguez-Leal, G	1
Frenette, CT; Levy, C; Saab, S	1
Brown, KA; Brown, RS; Flamm, SL; Rahimi, RS	1
Deltenre, P; Labenz, C; Schuchmann, M	1
Flamm, SL	2
Einstadter, D; Mullen, KD; Pantham, G; Post, A; Venkat, D	1
Arias, N; Hadjihambi, A; Jalan, R; Sheikh, M	1
Ahire, K; Sonawale, A	1
Carlstedt, R; Lam, A; Lee, J; Macy, B; Macygin, KMC	1
Baik, SK; Chang, Y; Cho, EJ; Cho, H; Cho, YY; Kang, SH; Kim, MY; Kim, YJ; Lee, JH; Lee, YB; Nam, JY; Yoo, JJ; Yoon, JH; Yu, SJ	1
de Lorenzo-Pinto, A; García-Sánchez, R; Lorenzo-Salinas, A	1
Wijdicks, EFM	1
Butt, NI; Butt, UI; Kakar, AATK; Malik, T; Siddiqui, AM	1
Dam, G; Gluud, LL; Kornerup, LS; Vilstrup, H	1
Neff, G; Zachry, W	1
Abd-Elsalam, S; Badawi, R; El-Kalla, F; Elfert, A; Elkhalawany, W; ElSawaf, MA; Elwan, N; Hawash, N; Soliman, S	1
Cai, XJ; Hu, CM; Wang, L	1
Berni, E; Conway, P; Currie, CJ; Di Maggio, P; Murphy, D; Poole, C; Whitehouse, J	1
Abdo-Francis, JM; Alla, SN; Camacho-Aguilera, J; Higuera-de-la-Tijera, F; Jiménez-Ponce, F; Pérez-Hernández, JL; Salas-Gordillo, F; Servín-Caamaño, AI	1
Abdin, AA; Elfert, AA; Elkhouly, RA; Hawash, NI; Shehata, HH; Soliman, HH; Soliman, SM	1
Bandyopadhyay, D; Banik, S; Bhattacherjee, S; Datta, S; Hasan, S; Saha, S	1
Albert, K; Galambos, I; Haktanirlar, G; Koris, A; Molnár, MA; Nath, A; Varga, Á; Vatai, G	1
Malfertheiner, P; Schulz, C; Schütte, K; Vasapolli, R; Vilchez-Vargas, R	1
Hudson, M; Schuchmann, M	1
Chu, P; Wang, W; Wang, Z	1
Bajaj, JS; Fagan, A; Gavis, EA; Gillevet, PM; Kassam, Z; Sikaroodi, M	1
Alsahhar, JS; Rahimi, RS	1
Bracke, B; De Waele, L; Francque, S; Geerinckx, B; Hellemans, R; Kerstens, J; Michielsen, P; Van Craenenbroeck, AH; Van Gaal, PJ; Vanwolleghem, T	1
Bajaj, JS; Biggins, SW; Fallon, MB; Garcia-Tsao, G; Kamath, PS; Lai, J; Maliakkal, B; O'Leary, JG; Reddy, KR; Subramanian, RM; Tandon, P; Thacker, LR; Thuluvath, PJ; Vargas, HE; Wong, F	1
Bloom, PP; Chung, RT	1
Chang, YH; Fang, CJ; Lin, YS; Shen, YC	1
Jain, L; Puri, SK; Sarin, S; Sharma, BC; Sharma, P; Srivastava, S	1
Sharma, BC; Sharma, P	2
Liang, H; Liu, Q; Peng, L; Song, J; Tong, M; Wen, J	1
Chen, JY; Hsin, IF; Huang, HC; Tseng, HS; Yang, SF; Yao, YH	1
Mukhopadhyay, C; Rodrigues, GS; Sekhar, MS; Unnikrishnan, MK	1
Goyal, R; Lunia, MK; Sarin, SK; Sharma, BC; Sharma, P; Srivastava, S	1
Chacko, KR; Sigal, SH	1
Kanna, S; Mullen, KD; Prakash, RK	1
Burman, BE; Kowdley, KV	1
El Yamany, SA; Hamisa, MF; Hasan, AM; Soliman, HH; Ziada, DH	1
Lunia, MK; Sachdeva, S; Sharma, BC; Sharma, P; Srivastava, S	1
Jalan, R; Jover-Cobos, M; Khetan, V	1
Kamath, PS; Kim, WR; Leise, MD; Poterucha, JJ	1
Morillas, RM; Planas, R; Sala, M	1
Kanna, S; Mullen, K; Waghray, A; Waghray, N	1
Congly, SE; Leise, MD	1
Chander, SB; Praveen, S	1
Kutepov, DE; Pasechnik, IN; Sal'nikov, PS; Vershinina, MG	1
Labenz, J	1
Hadjihambi, A; Jalan, R; Khetan, V	1
Cuthbert, JA; Rahimi, RS; Rockey, DC; Singal, AG	1
Doran, AE; Shah, NL	1
Lu, L; Patel, A; Sheasgreen, C	1
Jalan, R; Sawhney, R	1
Courson, A; Jones, GM; Twilla, JD	1
Blondel, N	1
Ahmed, MA; El-Deen Salem, MN; El-Dessouky, YM; El-Mola, K; El-Sayed, AM; El-Tiby, DM; Wahib, AA	1
Bañares, R; Vaquero, J	1
Cutler, T; Mints, G	1
Tapper, EB	1
Cuthbert, JA; Rahimi, RS; Rockey, DC	1
Chawla, R; Jindal, A; Maharshi, S; Sachdeva, S; Sharma, BC; Srivastava, S	1
Anderson, ME; Kalva, SP; Srinivasa, RN; Sutphin, PD	1
Utzt, MJ	1
Nguyen-Tat, M; Schattenberg, JM	1
Henderson, PK; Herrera, JL	1
Sussman, NL	1
Kodali, S; McGuire, BM	1
Goyal, O; Kishore, H; Parker, RA; Sidhu, SS; Sood, A	1
Chang, M; Finkelstein, D; Lai, M; Mittleman, MA; Piatkowski, G; Tapper, EB	1
Alper, TS; Au, J; Saab, EG; Saab, S; Suraweera, D; Tong, MJ	1
Maharshi, S; Puri, V; Sharma, BC; Singh, J; Srivastava, S	1
Khosravani, H; Perri, GA	1
Kliegis, LM; Kropf, S; Malfertheiner, P; Riegger, A; Schmitt, FC; Schulz, C; Schütte, K; Vasapolli, R	1
Wahlin, S	1
Cook, AK; Lidbury, JA; Steiner, JM	1
Gluud, LL; Morgan, MY; Vilstrup, H	2
Ampuero, J; Bellot, P; Figueruela, B; Francés, R; Gallego-Durán, R; González-Navajas, JM; Martínez-Moreno, B; Moratalla, A; Roger, M; Romero-Gómez, M; Such, J; Zapater, P	1
Sauerbruch, T	1
Colecchia, A; Festi, D; Marasco, G; Ravaioli, F	1
Bémeur, C; Rombouts, K; Rose, CF	1
Morgan, MY	2
Petite, SE	1
Bendtsen, F	1
Pena-Polanco, JE; Rondon-Berrios, H	1
Wijdicks, EF	1
Afifi, O; Bakry, A; El-Karaksy, HM; Kader, AA; Saber, N	1
Mantri, AK; Sangam, A; Sarin, SK; Sharma, BC; Singh, J; Srivastava, S; Trehanpati, N	1
Hami, F; Maggs, J; Sutherland, A	1
Allampati, S; Bajaj, JS; Fagan, AC; Farcomeni, A; Gavis, EA; Gioia, S; Mullen, KD; Nardelli, S; Prakash, R; Riggio, O; Unser, A; Wade, JB; White, MB	1
Puri, V; Sachdeva, S; Sharma, BC; Singh, J; Srivastava, S	1
Dalal, I; John, ES; Sedhom, R; Sharma, R	1
Dalal, R; McGee, RG; Riordan, SM; Webster, AC	1
Colle, I; De Keukeleire, K; Pauwels, W; Van Vlierberghe, H	1
Bajaj, JS	2
Akasaka, HM; de Oliveira Figueiredo, MJ; de Souza Almeida, JR; Lorena, SL; Mesquita, MA; Nagasako, CK; Pavan, CR; Pereira, TS; Soares, EC; Yamanaka, A	1
Agrawal, A; Sarin, SK; Sharma, BC; Sharma, P	4
Sarin, SK; Sharma, BC; Sharma, P	3
Shaikh, OS; Sundaram, V	1
Barritt, AS; Fried, MW; Hayashi, PH	1
Galvano, F; Gargante, MP; Li Volti, G; Malaguarnera, G; Malaguarnera, M; Mastrojeni, S; Pennisi, G; Rampello, L; Salmeri, M	1
Bajaj, JS; Bell, D; Gilles, H; Heuman, DM; Sanyal, AJ	1
Sharma, P	1
Bass, NM; Beavers, K; Bortey, E; Forbes, WP; Frederick, T; Hillebrand, D; Huang, S; Leevy, CB; Merchant, K; Mullen, KD; Neff, G; Poordad, F; Sanyal, A; Shaw, A; Sheikh, MY; Sigal, S; Teperman, L	1
Riordan, SM; Williams, R	1
Neff, G	2
Broadbridge, V; Kimber, R; Patterson, W; Pittman, K; Price, TJ; Sukumaran, S; Townsend, A	1
Cupo Abbott, J; Kim, JW; Phongsamran, PV; Rosenblatt, A	1
Abdo-Francis, JM; Hernández-Vásquez, JR; Hinojosa-Ruiz, A; Pérez-Hernández, JL	1
Braillon, A	2
Foster, KJ; Lin, S; Turck, CJ	1
Mullen, KD; Prakash, R	1
Bajaj, JS; Riggio, O	1
Abe, S; Akaboshi, S; Baba, H; Beppu, T; Eto, S; Furuhashi, S; Horino, K; Ida, S; Nakahara, O; Ozaki, N; Takamori, H; Tanaka, H	1
Mantry, PS; Munsaf, S	1
Gitlin, N	1
Spiegel, DR; Surkin, K	1
Owens, SL; Parnell, NK	1
Klinken, E; MacQuillan, G	1
Mittal, VV; Sarin, SK; Sharma, BC; Sharma, P	1
Wakim-Fleming, J	1
Lukens, B; Nierman, DM; Schiano, TD	1
Bajaj, JS; Gillevet, PM; Heuman, DM; Hylemon, PB; Ridlon, JM; Sikaroodi, M; Smith, S; Thacker, LR	1
Cao, WK; Li, L; Lu, CZ; Luo, M	1
Broda, T; Jonas, M; Jones, M; Kaiser, TE; Kemmer, N; Neff, GW; Novick, D; Ravi, R	1
Bakens, A; McGee, RG; Riordan, SM; Webster, AC; Wiley, K	1
Abbas, Z; Abid, S; Hamid, S; Islam, M; Jafri, W; Mumtaz, K; Shah, HA	1
Bajaj, JS; Heuman, DM; Pinkerton, SD; Sanyal, AJ	1
Rivera Ramos, JF; Rodríguez Leal, C	1
Khungar, V; Poordad, F	2
Amodio, P; Angeli, P; Montagnese, S	1
Stremmel, W; Zhan, T	1
Fehérvári, I; Gerlei, Z; Görög, D; Kóbori, L; Nemes, B	1
Ahluwalia, V; Bajaj, JS; Bell, DE; Crossey, MM; Fatouros, PP; Gillevet, PM; Heuman, DM; Hylemon, PB; Kettenmann, B; Patel, NR; Ridlon, JM; Schubert, CM; Sikaroodi, M; Taylor-Robinson, SD	1
Hattingen, E; Treusch, NA; van de Loo, S	1
Kawaguchi, T; Sata, M; Taniguchi, E	1
Häussinger, D; Kircheis, G	1
Jia, JD	1
Plauth, M	1
Muehlenberg, K	1
Alaniz, C; Mohammad, RA; Regal, RE	1
Aagaard, NK; Borre, M; Cordoba, J; Dam, G; Gluud, LL; Les, I; Marchesini, G; Vilstrup, H	1
Helewski, KJ; Konecki, JJ; Kowalczyk-Ziomek, GI	1
Schumann, C	1
Eleftheriadis, D; Eleftheriadis, N; Fourla, E; Karlovasitou, A	1
Il'chenko, LIu; Petrakov, AV; Shuliat'ev, IS; Sil'verstrova, SIu; Vinnitskaia, EV	1
Carmona Soria, I; García Montes, JM; Herrerías Gutiérrez, JM; Jiménez Sáenz, M; Quero Guillén, JC	1
Dai, SJ; Li, YY; Nie, YQ; Ping, L; Sha, WH; Zeng, Z	1
Solga, SF	1
Li, YY; Zeng, Z	1
Ueki, A	1
Maruyama, K; Shirakura, K	1
Dasarathy, S	1
Als-Nielsen, B; Gluud, C; Gluud, LL	2
Jalan, R; Shawcross, DL	1
Bongaerts, G; Severijnen, R; Timmerman, H	1
Dhanjal, NS; Oatridge, A; Patel, N; Taylor-Robinson, SD; White, S	1
Jia, L; Zhang, MH	1
Als-Nielsen, BE; Gluud, CN; Gluud, LL	1
Choi, SK; Joo, YE; Kim, HS; Kim, SJ; Park, CH; Rew, JS	1
Baker, DE	1
Bernauer, E; Finsterer, J	1
Godai, K; Munemura, C; Murawaki, Y; Noguchi, K; Uemasu, J; Yamamoto, S	1
Ahn, SH; Chon, CY; Han, KH; Kim, MH; Lee, DK; Lee, KS; Lee, SI; Lee, SJ; Moon, BS; Moon, YM; Paik, YH; Park, HJ; Song, KH	1
Gupta, RK; Hasan, KM; Kale, RA; Mishra, AM; Narayana, PA; Pandey, CM; Ranjan, P; Saraswat, VA; Trivedi, R	1
Buell, J; Duncan, C; Hess, K; Jonas, M; Kaiser, T; Kemmer, N; McHenry, R; Neff, GW; Novick, D; Thomas, M; Williamson, C; Zacharias, VC	1
Leevy, CB; Phillips, JA	1
Agarwal, R; Chawla, YK; Dhiman, RK; Duseja, A; Prasad, S; Sharma, A	1
Mullen, KD; Ogunwale, BO; Qadri, AM	1
Cho, KJ; Moustafa, T; Semiz-Oysu, A	1
Alisky, JM	1
Blei, A; Grüngreiff, K; Jalan, R; Kircheis, G; Marchesini, G; Morgan, MY; Riggio, O; Weissenborn, K	1
Björnsson, E; Kalaitzakis, E	1
Esrailian, E; Huang, E; Spiegel, BM	1
Gupta, M; Hunter, S; Tumialán, L; Tumialán, LM	1
Smith, GE; Stewart, CA	1
Hendriks, ME; Portegies, P; van Westerloo, DJ	1
Puri, V; Sarin, SK; Sharma, BC; Sharma, P	1
Misra, P	1
Hoyumpa, AM; Schenker, S	1
Altilia, F; Amadio, R; Cipollini, F	1
Juttijudata, P; Meensook, C	1
Pottala, EW; Shapiro, MB; Yaar, I	1
Schomerus, H	1
Crossley, IR; Williams, R	1
Koken, M; Reim, HG	1
Mörl, M	2
Newell, J	1
Beaven, JH	1
Desai, HG	1
Lauener, RW; Nanji, AA	1
Cangiano, C; Cascino, A; De Conciliis, D; Giunchi, G; Merli, M; Riggio, O; Rossi-Fanelli, F; Stortoni, M	1
Hoyumpa, AM; McGrew, WR; Nelson, DC	1
Gever, LN	1
Davidoff, S; Werbitt, W	1
Candelaresi, MT; Cavallini, G; Corazza, GR; Di Simone, A; Dobrilla, G; Freddara, U; Morettini, A; Orlandi, F	1
Baumgarten, R; Fengler, JD; Markus, R	1
Bircher, J; Bührer, M; Franz, K; van Velthuijsen, JA	1
Weber, FL	3
Martin, AJ	1
Borovac, N; Kulenović, S; Rezaković, D; Veljkov, N	1
Ferrieri, A; Massimetti, A; Puxeddu, A; Quartini, M	1
Hirata, Y; Kimura, K; Ozaki, T; Sato, S; Suzuki, K; Watanabe, M; Yoshikuni, Y	1
Campollo, O; Cortéz, R; Gutiérrez, M; Muñoz, RM; Odor, A	1
Chan, CY; Huang, YS; Jeng, WC; Lee, SD; Pai, CH	1
Filippini, SA; Kirkman, MS; Zimmerman, DR	1
Bachetti, P; Doherty-Simor, MM; LaBerge, JM; Lake, JR; Riegler, JL; Roberts, JP; Somberg, KA	1
Hirata, Y; Kimura, K; Mushiroi, T; Ozaki, T; Shibahara, R; Ukai, Y; Watanabe, M	1
Hirata, Y; Kimura, K; Ozaki, T; Watanabe, M; Yoshikuni, Y	1
Doffoël, M; Vetter, D	1
Allaz, JL; Blanc, P; Buttigieg, R; Daurès, JP; Desprez, D; Larrey, D; Liautard, J; Michel, H; Pageaux, G; Parelon, G	1
Perney, P; Pomier-Layrargues, G	1
Brogden, RN; Gillis, JC	1
Antezana, C; Chesta, J	1
Kawasaki, H; Murawaki, Y	1
Kato, M; Moriwaki, H; Murase, M; Muto, Y	1
Alegría, S; Antezana, C; Chesta, J	1
Bucci, L; Palmieri, GC	1
Fehér, J; Prónai, L	1
Cammà, C; Fabbri, A; Fiorello, F; Marchesini, G; Pagliaro, L; Tinè, F	1
Schomerus, H; Schreiegg, J	1
Abbiati, R; Coltorti, M; Del Vecchio Blanco, C; Loguercio, C; Rinaldi, M; Romano, A	1
Nolte, W; Ramadori, G	1
Eisenburg, J	1
Fukasawa, M; Futagawa, S	1
Daenens, C; Desager, JP; Geubel, AP; Horsmans, Y; Solbreux, PM	1
Moran, S; Muñoz, RM; Poo, JL; Uribe-Esquivel, M	1
Conn, HO	3
Clausen, MR; Mortensen, PB	1
Arakawa, Y; Fujiyama, S; Imai, F; Kawasaki, H; Kobayashi, K; Muto, Y; Ohto, M; Okita, K; Sakai, T; Sato, S; Shimada, S; Tanikawa, K; Toda, G; Tsujii, T; Watanabe, A	1
Jia, L; Li, Y	1
Bañares, R; Carneros, JA; Rincón, D	1
Agarwal, VP; Haseler, LJ; McCarthy, DM; Mojtahedzadeh, HN; Reddy, S; Sibbitt, WL	1
Hayes, PC; Jalan, R; Olde Damink, SW; Wardlaw, JM	1
Attili, AF; Hassan, C; Meddi, P; Rinaldi, V; Winn, S; Zullo, A	1
Blei, AT	1
Chawla, YK; Das, G; Dhiman, RK; Dilawari, JB; Ram, S; Sawhney, MS	1
Blei, AT; Córdoba, J	1
Kawata, S; Saito, T; Shinzawa, H; Togashi, H; Watanabe, H	1
Holovach, IIu; Mytnyk, ZM; Neĭko, IeM	1
Dicheva, DT; Iakovenko, EI; Lebedeva, EG; Maev, IV; V'iuchnova, ES	1
Conn, HO; Leevy, CM; Levy, LL; Maddrey, WC; Rodgers, JB; Seeff, L; Vlahcevic, ZR	1
Grijm, R	1
Borkar, BB; Kadian, RS; Mann, NS; Mann, SK; Martin, RL; Narenderan, KP	1
Wienbeck, M	1
Chamuleau, RA	1
Bergonzi, P; Bianco, A; Mazza, S; Mennuni, G	1
Badley, BW	1
Hicks, EP; Hislop, IG; Ratnaike, RN	1
Gupta, JK; Ingegno, AP; Zimmerman, AL	1
Busse, HJ; Nilius, R; Otto, L; Zipprich, B	1
Bettinger, I; Beyer, P; Carley, J; Greenberger, NJ; Schenker, S; Stamnes, C	1
Atterbury, CE; Conn, HO; Maddrey, WC	1
Avant, GR; Desmond, PV; Hoyumpa, AM; Roberts, RK; Schenker, S	1
Bode, JC; Reiter, HJ	1
Demeulenaere, L; van Egmond, J; Van Waes, L	1
Ancarani, E; Casciani, CU	1
Bossone, CM	1
Glouberman, S	1
Leonhardt, H; Sanhueza, P	1
Matthews, SJ	1
Dölle, W	1
Vanovski, B	1
Imler, M	2
Müting, D	2
Chevrel, B	1
Kosman, ME	1
Thaler, H	1
Arcuri, F; Rizzo, F	1
Maddrey, WC; Weber, FL	1
Bergonzi, P; Bianco, S; Borzone, A; Butti, A; Cagossi, M; Civello, IM; Nanni, G; Pigliucci, GM	1
Ferrari, A; Manenti, F	1
Caschera, M; Diofebi, M; Merli, M; Piat, C; Pinto, G; Riggio, O	1
Blanc, P; Daures, JP; Gremy, F; Larrey, D; Michel, H; Peray, P; Pierrugues, R; Rouillon, JM	1
Bhist, MS; Dasarathy, S; Gupta, S; Jain, S; Sushma, S; Tandon, RK	1
Mullen, KD; Weber, FL	1
Hong, RW; Rodrick, ML; Rounds, JD; van Leeuwen, PA; Wilmore, D	1
Capocaccia, L; Merli, M; Riggio, O	1
Hayashi, K; Ikeda, T; Ito, T; Karube, H; Mizuno, T; Nomoto, T; Okada, T; Sakurai, A; Shindo, K; Tarao, K	1
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Riggio, O; Tremiterra, S; Ziparo, V	1
Bird, SP; Gurr, MI; Hewitt, D; Ratcliffe, B	1
Bobrowska, E; Boroń, P; Flisiak, R; Kaczmarska, A; Nowak, HF; Szpakowicz, T; Zimnoch, L	1
Bonnén, H; Clausen, MR; Holtug, K; Mortensen, PB	1
Capocaccia, L; Riggio, O	1
Lambert, R; Prat, F	1
Hayashi, K; Ikeda, T; Sakurai, A; Tarao, K	1
Alonso, M; Morgan, MY; Stanger, LC	1
Ariosto, F; Balducci, G; Capocaccia, L; Merli, M; Pieche, U; Pinto, G; Riggio, O; Tremiterra, S; Ziparo, V	1
Jensen, DM	1
DiPalma, JR	1
Arieff, AI; Fraser, CL	1
Heredia, D; Orteu, N; Rodés, J; Terés, J	1
Maier, KP	1
Hayashi, K; Ikeda, T; Ito, T; Okada, T; Sakurai, A; Tarao, K; Tsuchiya, T	1
Minuk, GY; Sarjeant, EJ	1
Hawley, KE; Morgan, MY; Stambuk, D	1
Sherlock, S	1
Holtug, K; Mortensen, PB; Rasmussen, HS	1
Clark, ML; Dawson, AM; Mahida, YR; Palmer, KR; Patil, DH; Rees, R; Silk, DB; Westaby, D	1
Arroyo, V; Caballería, J; Heredia, D; Ravelli, G; Rodés, J	1
Schafer, DF	1
Palmieri, V; Tardi, S; Ventrella, F	1
Mann, NS; Mann, SK; Russman, HB; Tsai, MF	1
Maddrey, WC	1
Lanthier, PL; Morgan, MY	1
Jenkins, SA; Skerritt, GC	1
Haerting, J; Mantel, E; Nilius, R; Rink, C	1
Neumayr, A	1
Fischer, JE	1
Seidlová, V	1
Devos, J; Guffens, JM; Pirotte, J	1
Bell, B; Jacobson, S	1
Balint, JA; Kiley, JE; Rodgers, JB	1
Breen, KJ; Hoyumpa, AM; Schenker, S	1
Dawson, AM; Drinkwater, JE; O'Grady, F; Vince, A; Zeegen, R	1
Conn, HO; Fessel, JM	1
Almici, C; Inzoli, MR; Poloni, AE; Zambruni, A	1
Barrios, JM; Berenguer, J; Gómez, J; Sala Felis, T	1
Boonstra, S; Gips, CH; Qué, GS; Van Der Zwan, JC	1

Reviews

128 review(s) available for lactulose and Encephalopathy, Hepatic

Article	Year
Comparative Effectiveness and Safety of Polyethylene Glycol Electrolyte Solution Versus Lactulose for Treatment of Hepatic Encephalopathy: A Systematic Review and Meta-analysis. Journal of clinical gastroenterology, 2022, 01-01, Volume: 56, Issue:1 Topics: Electrolytes; Hepatic Encephalopathy; Humans; Lactulose; Polyethylene Glycols; Randomized Controlled Trials as Topic; Treatment Outcome	2022
Is rifaximin better than nonabsorbable disaccharides in hepatic encephalopathy?: A meta-analysis. Medicine, 2021, Dec-23, Volume: 100, Issue:51 Topics: Anti-Bacterial Agents; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Pharmaceutical Preparations; Rifamycins; Rifaximin	2021
Heretical thoughts into hepatic encephalopathy. Journal of hepatology, 2022, Volume: 77, Issue:2 Topics: Hepatic Encephalopathy; Humans; Lactulose; Rifamycins	2022
Combination therapy with rifaximin and lactulose in hepatic encephalopathy: A systematic review and meta-analysis. PloS one, 2022, Volume: 17, Issue:4 Topics: Combined Modality Therapy; Hepatic Encephalopathy; Humans; Lactulose; Rifaximin; Treatment Outcome	2022
Inadequate practices for hepatic encephalopathy management in the inpatient setting. Journal of hospital medicine, 2022, Volume: 17 Suppl 1 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Rifaximin	2022
Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis. BioMed research international, 2022, Volume: 2022 Topics: Breath Tests; Hepatic Encephalopathy; Humans; Intestine, Small; Lactulose; Liver Cirrhosis	2022
Systematic Review and Meta-Analysis on the Effects of Lactulose and Rifaximin on Patient-Reported Outcomes in Hepatic Encephalopathy. The American journal of gastroenterology, 2023, 02-01, Volume: 118, Issue:2 Topics: Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Prospective Studies; Quality of Life; Rifamycins; Rifaximin	2023
Hepatic encephalopathy - recent advances in treatment and diagnosis. Expert review of gastroenterology & hepatology, 2023, Volume: 17, Issue:3 Topics: Anti-Bacterial Agents; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifaximin	2023
Active Clinical Trials in Hepatic Encephalopathy: Something Old, Something New and Something Borrowed. Neurochemical research, 2023, Volume: 48, Issue:8 Topics: Animals; Anti-Infective Agents; Hepatic Encephalopathy; Horses; Lactulose; Quality of Life; Rifaximin	2023
Hepatic Encephalopathy: Diagnostic Tools and Management Strategies. The Medical clinics of North America, 2023, Volume: 107, Issue:3 Topics: Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Lactulose; Quality of Life; Rifaximin	2023
Comparative Efficacy of Treatment Options for the Prevention of Post-TIPS Hepatic Encephalopathy: A Systematic Review and Network Meta-analysis. Journal of gastrointestinal and liver diseases : JGLD, 2023, 04-01, Volume: 32, Issue:1 Topics: Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Network Meta-Analysis; Rifaximin	2023
Diagnosis and Management of Cirrhosis and Its Complications: A Review. JAMA, 2023, 05-09, Volume: 329, Issue:18 Topics: Adult; Ascites; Carvedilol; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatorenal Syndrome; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Muscle Cramp; Propranolol; Randomized Controlled Trials as Topic; Sodium Potassium Chloride Symporter Inhibitors; Terlipressin; United States	2023
Management of minimal and overt hepatic encephalopathy with branched-chain amino acids: a review of the evidence. European journal of gastroenterology & hepatology, 2023, 08-01, Volume: 35, Issue:8 Topics: Amino Acids, Branched-Chain; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifaximin	2023
Primary prevention of hepatic encephalopathy post-TIPS: A systematic review and meta-analysis. Medicine, 2023, Sep-22, Volume: 102, Issue:38 Topics: Albumins; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Primary Prevention; Rifaximin	2023
Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:4 Topics: Hepatic Encephalopathy; Humans; Lactulose; Network Meta-Analysis; Quality of Life	2020
Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach. Clinics in liver disease, 2019, Volume: 23, Issue:4 Topics: Amino Acids, Branched-Chain; Ammonia; Caregivers; Cost of Illness; Dipeptides; Embolization, Therapeutic; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Neomycin; Patient Readmission; Rifaximin; Severity of Illness Index; Sodium Benzoate; Sorption Detoxification; Zinc	2019
Clinical management of type C hepatic encephalopathy. United European gastroenterology journal, 2020, Volume: 8, Issue:5 Topics: Administration, Oral; Anti-Bacterial Agents; Drug Therapy, Combination; Endovascular Procedures; Enema; Hepatic Encephalopathy; Hepatic Veins; Humans; Imaging, Three-Dimensional; Lactulose; Liver Cirrhosis; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Portal Vein; Prevalence; Psychometrics; Rifaximin; Severity of Illness Index; Stents; Tomography, X-Ray Computed; Urinary Tract Infections	2020
Pharmacologic Management of Hepatic Encephalopathy. Clinics in liver disease, 2020, Volume: 24, Issue:2 Topics: Acarbose; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Fecal Microbiota Transplantation; Flumazenil; GABA Modulators; Glycerol; Glycoside Hydrolase Inhibitors; Hepatic Encephalopathy; Humans; Lactulose; Laxatives; Phenylbutyrates; Probiotics; Rifaximin	2020
The Health Care Burden of Hepatic Encephalopathy. Clinics in liver disease, 2020, Volume: 24, Issue:2 Topics: Cost of Illness; Emergency Service, Hospital; Gastrointestinal Agents; Health Care Costs; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Length of Stay; Patient Admission; Patient Readmission; Quality of Life; Rifaximin	2020
Social Impact of Hepatic Encephalopathy. Clinics in liver disease, 2020, Volume: 24, Issue:2 Topics: Activities of Daily Living; Automobile Driving; Caregivers; Employment; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Quality of Life; Rifaximin; Sleep Wake Disorders	2020
Non-Lactulose Medication Therapies for the Management of Hepatic Encephalopathy: A Literature Review. Journal of pharmacy practice, 2021, Volume: 34, Issue:6 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Polyethylene Glycols; Probiotics; Randomized Controlled Trials as Topic; Rifaximin	2021
Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis. BMJ open gastroenterology, 2021, Volume: 8, Issue:1 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Polyethylene Glycols	2021
Current approach to treatment of minimal hepatic encephalopathy in patients with liver cirrhosis. World journal of gastroenterology, 2021, Jun-14, Volume: 27, Issue:22 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Quality of Life; Rifaximin	2021
Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door. Digestive diseases and sciences, 2022, Volume: 67, Issue:6 Topics: Aftercare; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Liver Cirrhosis; Patient Discharge; Patient Transfer; Quality of Life; Rifaximin	2022
Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes. The American journal of medicine, 2021, Volume: 134, Issue:11 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Length of Stay; Mortality; Ornithine; Rifaximin; Secondary Prevention	2021
Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP. The Journal of family practice, 2017, Volume: 66, Issue:4 Suppl Topics: Anti-Bacterial Agents; Carcinoma, Hepatocellular; Early Detection of Cancer; Education, Medical, Continuing; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Practice Guidelines as Topic; Prevalence; Primary Health Care; Risk Factors; United States	2017
Hepatic encephalopathy: a critical current review. Hepatology international, 2018, Volume: 12, Issue:Suppl 1 Topics: Albumins; Ammonia; Anti-Bacterial Agents; Bile Acids and Salts; Brain; Brain Edema; Cognitive Dysfunction; Dipeptides; Energy Metabolism; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Portasystemic Shunt, Surgical; Prognosis; Psychometrics; Severity of Illness Index; Synaptic Transmission	2018
Lactulose: A Simple Sugar in a Complex Encephalopathy. Neurocritical care, 2018, Volume: 28, Issue:2 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; History, 20th Century; Humans; Lactulose	2018
Update on the Therapeutic Management of Hepatic Encephalopathy. Current gastroenterology reports, 2018, Apr-11, Volume: 20, Issue:5 Topics: Amino Acids, Branched-Chain; Anti-Bacterial Agents; Disease Management; Fecal Microbiota Transplantation; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Probiotics; Rifamycins; Rifaximin	2018
Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin. PharmacoEconomics, 2018, Volume: 36, Issue:7 Topics: Anti-Bacterial Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Health Care Costs; Hepatic Encephalopathy; Humans; Lactulose; Rifaximin	2018
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy. The American journal of the medical sciences, 2018, Volume: 356, Issue:3 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifaximin	2018
Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System. Medicina (Kaunas, Lithuania), 2018, Apr-17, Volume: 54, Issue:2 Topics: Cathartics; Colonic Neoplasms; Constipation; Diarrhea; Galactosides; Gastrointestinal Diseases; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Inflammatory Bowel Diseases; Lactose; Lactulose; Oligosaccharides; Prebiotics; Probiotics; Sugar Alcohols; Trisaccharides	2018
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence. European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:4 Topics: Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Recurrence; Rifaximin; Secondary Prevention	2019
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy. Drug design, development and therapy, 2019, Volume: 13 Topics: Adult; Aged; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Rifaximin; Treatment Outcome	2019
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy. Current opinion in gastroenterology, 2019, Volume: 35, Issue:3 Topics: Amino Acids, Aromatic; Amino Acids, Branched-Chain; Ammonia; Dipeptides; Fecal Microbiota Transplantation; Frailty; Gastrointestinal Agents; Gastrointestinal Microbiome; Glycerol; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Ornithine; Phenylbutyrates; Polyethylene Glycols; Probiotics; Rifaximin; Trace Elements; Zinc	2019
A rare case of hemodialysis-related portosystemic encephalopathy and review of the literature. Acta clinica Belgica, 2020, Volume: 75, Issue:4 Topics: Brain; Femoral Vein; Gastrointestinal Agents; Glucocorticoids; Hepatic Encephalopathy; Humans; Kidney Failure, Chronic; Lactulose; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Polycystic Kidney, Autosomal Recessive; Portasystemic Shunt, Transjugular Intrahepatic; Renal Dialysis; Vena Cava, Superior; White Dot Syndromes; Young Adult	2020
Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis. Nutrition journal, 2019, 07-06, Volume: 18, Issue:1 Topics: Dietary Supplements; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Treatment Outcome; Zinc	2019
Disaccharides in the treatment of hepatic encephalopathy. Metabolic brain disease, 2013, Volume: 28, Issue:2 Topics: Animals; Anti-Infective Agents; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Sugar Alcohols	2013
Update on management of patients with overt hepatic encephalopathy. Hospital practice (1995), 2013, Volume: 41, Issue:3 Topics: Disease Management; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin; Secondary Prevention; Severity of Illness Index	2013
Evolving concepts: the negative effect of minimal hepatic encephalopathy and role for prophylaxis in patients with cirrhosis. Clinical therapeutics, 2013, Volume: 35, Issue:9 Topics: Anti-Infective Agents; Clinical Trials as Topic; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Probiotics; Quality of Life; Rifamycins; Rifaximin	2013
Treatment of hyperammonemia in liver failure. Current opinion in clinical nutrition and metabolic care, 2014, Volume: 17, Issue:1 Topics: Ammonia; Brain; Glycerol; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Phenylbutyrates; Probiotics; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2014
Management of hepatic encephalopathy in the hospital. Mayo Clinic proceedings, 2014, Volume: 89, Issue:2 Topics: Disease Management; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Metronidazole; Neomycin; Protein Synthesis Inhibitors; Recurrence; Rifamycins; Rifaximin; Terminology as Topic	2014
[Prevention of hepatic encephalopathy]. Medicina clinica, 2014, Jun-06, Volume: 142, Issue:11 Topics: Anti-Bacterial Agents; Central Nervous System Depressants; Contraindications; Diuretics; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Intestinal Absorption; Lactulose; Liver Cirrhosis; Liver Transplantation; Meta-Analysis as Topic; Peritonitis; Portasystemic Shunt, Surgical; Postoperative Complications; Recurrence; Rifamycins; Rifaximin; Risk Factors; Sugar Alcohols	2014
Optimal treatment of hepatic encephalopathy. Minerva gastroenterologica e dietologica, 2014, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Practice Guidelines as Topic; Probiotics; Quality of Life; Rifamycins; Rifaximin; Severity of Illness Index; Treatment Outcome; United States	2014
[Pay more attention to hepatic encephalopathy]. MMW Fortschritte der Medizin, 2014, Feb-06, Volume: 156, Issue:2 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Long-Term Care; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Survival Rate	2014
Pharmacotherapy for hyperammonemia. Expert opinion on pharmacotherapy, 2014, Volume: 15, Issue:12 Topics: Ammonia; Animals; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Rifamycins; Rifaximin; Sorption Detoxification	2014
Pathophysiology, diagnosis, and management of hepatic encephalopathy. Inflammopharmacology, 2014, Volume: 22, Issue:6 Topics: Ammonia; Anti-Bacterial Agents; Anti-Inflammatory Agents; Hepatic Encephalopathy; Humans; Inflammation; Lactulose; Liver Cirrhosis	2014
Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What? Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Dipeptides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Patient Selection; Probiotics; Rifamycins; Rifaximin; Severity of Illness Index; Sickness Impact Profile	2015
Treatment of Overt Hepatic Encephalopathy. Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Amino Acids, Branched-Chain; Ammonia; Arteriovenous Fistula; Dipeptides; Gastrointestinal Agents; Glycerol; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Malnutrition; Ornithine; Phenylbutyrates; Probiotics; Rifamycins; Rifaximin	2015
Diagnosis and Management of Hepatic Encephalopathy in Fulminant Hepatic Failure. Clinics in liver disease, 2015, Volume: 19, Issue:3 Topics: Acetylcysteine; Ammonia; Brain Edema; Free Radical Scavengers; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intracranial Pressure; Lactulose; Liver Failure, Acute; Neuroimaging; Neuropsychological Tests; Nutritional Support; Rifamycins; Rifaximin	2015
Probiotics are helpful in hepatic encephalopathy: a meta-analysis of randomized trials. Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:7 Topics: Disease Progression; Hepatic Encephalopathy; Hospitalization; Lactulose; Liver Cirrhosis; Probiotics; Randomized Controlled Trials as Topic	2016
Complications of end-stage liver disease. Canadian family physician Medecin de famille canadien, 2016, Volume: 62, Issue:1 Topics: Adrenergic beta-Antagonists; Anti-Bacterial Agents; Ascites; Bacterial Infections; Disease Management; End Stage Liver Disease; Esophageal and Gastric Varices; Esophagoscopy; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Lactulose; Ligation; Middle Aged; Palliative Care; Paracentesis; Peritonitis	2016
[Hepatic encephalopathy – the acute management]. Lakartidningen, 2016, 03-15, Volume: 113 Topics: Diagnosis, Differential; Disease Management; Emergency Treatment; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	2016
Hepatic encephalopathy in dogs and cats. Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001), 2016, Volume: 26, Issue:4 Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Hepatic Encephalopathy; Humans; Lactulose; Prognosis; Rifamycins; Rifaximin	2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane database of systematic reviews, 2016, Apr-18, Volume: 4 Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Sugar Alcohols	2016
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis. The Cochrane database of systematic reviews, 2016, May-06, Issue:5 Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols; Watchful Waiting	2016
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides. Metabolic brain disease, 2016, Volume: 31, Issue:6 Topics: Ammonia; Animals; Disaccharides; Gastrointestinal Agents; Health Knowledge, Attitudes, Practice; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Randomized Controlled Trials as Topic; Sugar Alcohols	2016
Hepatic Encephalopathy. The New England journal of medicine, 2016, Oct-27, Volume: 375, Issue:17 Topics: Brain Edema; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose	2016
Probiotics for people with hepatic encephalopathy. The Cochrane database of systematic reviews, 2017, 02-23, Volume: 2 Topics: Cause of Death; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Probiotics; Quality of Life; Randomized Controlled Trials as Topic	2017
Management options for minimal hepatic encephalopathy. Expert review of gastroenterology & hepatology, 2008, Volume: 2, Issue:6 Topics: Cognition; Hepatic Encephalopathy; Humans; Lactulose; Probiotics; Psychometrics	2008
Hepatic encephalopathy: pathophysiology and emerging therapies. The Medical clinics of North America, 2009, Volume: 93, Issue:4 Topics: Ammonia; Anti-Infective Agents; Drug Therapy, Combination; Dyskinesias; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver; Liver Cirrhosis; Liver, Artificial; Manganese; Metronidazole; Neomycin; Neuropsychological Tests; Portasystemic Shunt, Transjugular Intrahepatic; Protein-Energy Malnutrition; Recurrence; Rifamycins; Rifaximin; Trace Elements; Zinc	2009
Review article: the modern management of hepatic encephalopathy. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:5 Topics: Algorithms; Ambulatory Care; Cognition Disorders; Diagnosis, Differential; Disease Progression; Electroencephalography; Event-Related Potentials, P300; Flicker Fusion; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Transplantation; Neuropsychological Tests; Psychometrics; Rifamycins; Rifaximin; Risk Factors; Severity of Illness Index; United States	2010
Minimal hepatic encephalopathy. The Journal of the Association of Physicians of India, 2009, Volume: 57 Topics: Activities of Daily Living; Attention Deficit Disorder with Hyperactivity; Automobile Driving; Cognition Disorders; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; India; Lactulose; Liver Cirrhosis; Neuropsychological Tests; Prevalence; Psychometrics; Quality of Life; Risk Factors	2009
Factors affecting compliance and persistence with treatment for hepatic encephalopathy. Pharmacotherapy, 2010, Volume: 30, Issue:5 Pt 2 Topics: Drug Costs; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Liver Cirrhosis; Patient Compliance; Rifamycins; Rifaximin	2010
Pharmacoeconomics of hepatic encephalopathy. Pharmacotherapy, 2010, Volume: 30, Issue:5 Pt 2 Topics: Cost of Illness; Economics, Pharmaceutical; End Stage Liver Disease; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Rifamycins; Rifaximin	2010
Pharmacotherapy for hepatic encephalopathy. Drugs, 2010, Jun-18, Volume: 70, Issue:9 Topics: Anti-Infective Agents; Clinical Trials as Topic; Disaccharides; Hepatic Encephalopathy; Hepatic Insufficiency; Humans; Lactulose; Portasystemic Shunt, Transjugular Intrahepatic	2010
Current and emerging strategies for treating hepatic encephalopathy. Critical care nursing clinics of North America, 2010, Volume: 22, Issue:3 Topics: Acarbose; Anti-Bacterial Agents; Carnitine; Dyskinesias; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Probiotics; Risk Factors	2010
Mechanisms, diagnosis and management of hepatic encephalopathy. Nature reviews. Gastroenterology & hepatology, 2010, Volume: 7, Issue:9 Topics: Ammonia; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Rifamycins; Rifaximin	2010
Hepatic encephalopathy: suspect it early in patients with cirrhosis. Cleveland Clinic journal of medicine, 2011, Volume: 78, Issue:9 Topics: Diagnosis, Differential; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Oxidative Stress; Risk Factors; Severity of Illness Index; Time Factors	2011
Clinical efficacy and safety of lactulose for minimal hepatic encephalopathy: a meta-analysis. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:12 Topics: Adult; Ammonia; Diarrhea; Disease Progression; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome	2011
Probiotics for patients with hepatic encephalopathy. The Cochrane database of systematic reviews, 2011, Nov-09, Issue:11 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Probiotics; Quality of Life; Randomized Controlled Trials as Topic	2011
Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Annals of hepatology, 2011, Volume: 10 Suppl 2 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Transplantation; Neuropsychological Tests; Rifamycins; Rifaximin; Severity of Illness Index; Terminology as Topic	2011
Management of overt hepatic encephalopathy. Clinics in liver disease, 2012, Volume: 16, Issue:1 Topics: Acarbose; Ammonia; Disease Management; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin	2012
The diagnosis and treatment of minimal hepatic encephalopathy. Deutsches Arzteblatt international, 2012, Volume: 109, Issue:10 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Rifamycins; Rifaximin	2012
[Hepatic encephalopathy and liver transplantation]. Magyar sebeszet, 2012, Volume: 65, Issue:2 Topics: Ammonia; Anti-Infective Agents; Colon; Dipeptides; Disaccharides; End Stage Liver Disease; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hungary; Hydrogen-Ion Concentration; Lactobacillus; Lactulose; Laxatives; Liver Cirrhosis; Liver Transplantation; Metronidazole; Neomycin; Rifamycins; Rifaximin; Severity of Illness Index; Sugar Alcohols; Systemic Inflammatory Response Syndrome; Treatment Outcome	2012
Hepatic encephalopathy. Clinics in liver disease, 2012, Volume: 16, Issue:2 Topics: Ammonia; Anti-Bacterial Agents; Antidotes; Charcoal; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Prebiotics; Probiotics; Rifamycins; Rifaximin	2012
[Hepatic encephalopathy]. Deutsche medizinische Wochenschrift (1946), 2012, Volume: 137, Issue:31-32 Topics: Amino Acids, Branched-Chain; Ammonia; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Automobile Driving; Brain; Diet, Protein-Restricted; Disability Evaluation; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Ibuprofen; Indomethacin; Lactulose; Nerve Net; Neuroglia; Neurologic Examination; Neuronal Plasticity; Neuropsychological Tests; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Probiotics; Prognosis; Rifamycins; Rifaximin	2012
Combination therapy for the treatment and prevention of hepatic encephalopathy. The Annals of pharmacotherapy, 2012, Volume: 46, Issue:11 Topics: Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Probiotics; Rifamycins; Rifaximin	2012
Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence? Metabolic brain disease, 2013, Volume: 28, Issue:2 Topics: Amino Acids, Branched-Chain; Anti-Bacterial Agents; Disaccharides; Evidence-Based Medicine; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Rifamycins; Rifaximin	2013
[Therapeutic management of hepatic encephalopathy]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2002, Volume: 55, Issue:5-6 Topics: Anti-Bacterial Agents; Disease Progression; Flumazenil; Hepatic Encephalopathy; Humans; Lactulose; Liver Transplantation; Treatment Outcome	2002
Medical, nutritional and technological properties of lactulose. An update. European journal of nutrition, 2002, Volume: 41 Suppl 1 Topics: Animals; Bile Acids and Salts; Carrier State; Constipation; Endotoxins; Gastrointestinal Agents; Gastrointestinal Diseases; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactobacillus; Lactulose; Neoplasms; Salmonella Infections	2002
[Chronic liver disease]. Ryoikibetsu shokogun shirizu, 2003, Issue:40 Topics: Amino Acids, Branched-Chain; Chronic Disease; Diagnosis, Differential; Diet, Protein-Restricted; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases	2003
[Hepatic encephalopathy]. Ryoikibetsu shokogun shirizu, 2003, Issue:40 Topics: Alcoholism; Amino Acids, Branched-Chain; Ammonia; Blood-Brain Barrier; Embolization, Therapeutic; Hepatic Encephalopathy; Humans; Lactulose; Magnetic Resonance Imaging; Neurotransmitter Agents; Phenols; Psychometrics; Receptors, Neurotransmitter; Severity of Illness Index; Sulfhydryl Compounds	2003
Role of gut bacteria in the therapy of hepatic encephalopathy with lactulose and antibiotics. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2003, Volume: 22 Suppl 2 Topics: Ammonia; Anti-Bacterial Agents; Bacteria; Dietary Fiber; Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Sodium Benzoate	2003
Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials. BMJ (Clinical research ed.), 2004, May-01, Volume: 328, Issue:7447 Topics: Anti-Infective Agents; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic; Sugar Alcohols; Treatment Outcome	2004
Nonabsorbable disaccharides for hepatic encephalopathy. The Cochrane database of systematic reviews, 2004, Issue:2 Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Randomized Controlled Trials as Topic; Sugar Alcohols	2004
[Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]. Ugeskrift for laeger, 2005, Jan-10, Volume: 167, Issue:2 Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Sugar Alcohols	2005
Rifaximin: a nonabsorbed oral antibiotic. Reviews in gastroenterological disorders, 2005,Winter, Volume: 5, Issue:1 Topics: Anti-Infective Agents; Diarrhea; Escherichia coli Infections; Gases; Hepatic Encephalopathy; Humans; Inflammatory Bowel Diseases; Intestinal Absorption; Intestines; Lactulose; Microbial Sensitivity Tests; Rifampin; Rifamycins; Rifaximin	2005
The treatment of hepatic encephalopathy. Metabolic brain disease, 2007, Volume: 22, Issue:3-4 Topics: Amino Acids, Branched-Chain; Anti-Bacterial Agents; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Zinc	2007
Minimal hepatic encephalopathy. Nature clinical practice. Gastroenterology & hepatology, 2007, Volume: 4, Issue:12 Topics: Diagnosis, Differential; Diagnostic Imaging; Gastrointestinal Agents; Global Health; Hepatic Encephalopathy; Humans; Incidence; Lactulose; Liver Transplantation; Severity of Illness Index; Survival Rate	2007
Perspectives in hepatic encephalopathy. The Journal of laboratory and clinical medicine, 1982, Volume: 100, Issue:4 Topics: Amino Acids; Animals; Blood-Brain Barrier; Brain; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver; Neurotransmitter Agents; Toxins, Biological	1982
[Therapy of hepatic encephalopathy. Personal experience and a review of the literature]. Giornale di clinica medica, 1982, Volume: 63, Issue:10 Topics: Amino Acids; Ammonia; Bromocriptine; Electroencephalography; Fatty Acids; Hepatic Encephalopathy; Lactulose; Levodopa; Neomycin; Nervous System; Neurologic Examination; Neurotransmitter Agents; Sulfhydryl Compounds; Synaptic Transmission	1982
[Therapy of hepatic coma]. Zeitschrift fur Gastroenterologie. Verhandlungsband, 1983, Volume: 18 Topics: Amino Acids, Branched-Chain; Anti-Bacterial Agents; Brain; Bromocriptine; Cathartics; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Milk Proteins; Plant Proteins	1983
Progress in the treatment of chronic portasystemic encephalopathy. Gut, 1984, Volume: 25, Issue:1 Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin	1984
[Treatment with lactulose. A low-risk alternative in various diseases]. Fortschritte der Medizin, 1984, Dec-06, Volume: 102, Issue:45 Topics: Adolescent; Adult; Child; Child, Preschool; Constipation; Disaccharides; Hepatic Encephalopathy; Humans; Infant; Lactulose; Salmonella enteritidis; Salmonella Infections	1984
[Is the "specific" treatment of acute hepatic encephalopathy during liver cirrhosis justified?]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:12 Topics: Acute Disease; Drug Therapy, Combination; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Mannitol; Neomycin; Therapeutic Irrigation	1994
[Hepatic encephalopathy. Physiopathology and treatment]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:12 Topics: Amino Acids; Anti-Bacterial Agents; Drug Therapy, Combination; Flumazenil; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Portacaval Shunt, Surgical	1994
Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria. Drugs, 1995, Volume: 49, Issue:3 Topics: Diarrhea; Diverticulum, Colon; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Neomycin; Paromomycin; Rifamycins; Rifaximin	1995
[Pathogenesis and treatment of hepatic encephalopathy]. Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:1 Topics: Anti-Bacterial Agents; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	1994
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis. Digestive diseases and sciences, 1993, Volume: 38, Issue:5 Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Treatment Outcome	1993
[Therapy of hepatic encephalopathy]. Deutsche medizinische Wochenschrift (1946), 1996, May-24, Volume: 121, Issue:21 Topics: Acute Disease; Controlled Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Recurrence	1996
[Hepatic minimal encephalopathy. The most frequently overlooked, clinically occult "metabolic syndrome" on the cirrhosis patient]. Fortschritte der Medizin, 1996, Apr-30, Volume: 114, Issue:12 Topics: Ammonia; Arginine; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Prognosis; Psychometrics	1996
[Eck fistula syndrome]. Ryoikibetsu shokogun shirizu, 1995, Issue:7 Topics: Amino Acids, Branched-Chain; Hepatic Encephalopathy; Humans; Lactulose; Portacaval Shunt, Surgical; Postoperative Complications; Prognosis; Syndrome	1995
Lactulose and combination therapy of hepatic encephalopathy: the role of the intestinal microflora. Digestive diseases (Basel, Switzerland), 1996, Volume: 14 Suppl 1 Topics: Ammonia; Anti-Bacterial Agents; Bacteria; Cathartics; Dietary Fiber; Drug Synergism; Feces; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Liver; Neomycin; Neurotoxins; Nitrogen; Urea	1996
Effects of lactulose on nitrogen metabolism. Scandinavian journal of gastroenterology. Supplement, 1997, Volume: 222 Topics: Ammonia; Animals; Anti-Bacterial Agents; Colon; Dietary Fiber; Feces; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Nitrogen; Urea	1997
A clinical hepatologist's predictions about non-absorbed carbohydrates for the early twenty-first century. Scandinavian journal of gastroenterology. Supplement, 1997, Volume: 222 Topics: Cathartics; Forecasting; Gastroenterology; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	1997
Lactulose, disaccharides and colonic flora. Clinical consequences. Drugs, 1997, Volume: 53, Issue:6 Topics: Animals; Cathartics; Colon; Constipation; Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	1997
[Subclinical hepatic encephalopathy]. Zhonghua nei ke za zhi, 1996, Volume: 35, Issue:7 Topics: Evoked Potentials; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Wechsler Scales	1996
[New treatments of hepatic encephalopathy]. Gastroenterologia y hepatologia, 1998, Volume: 21, Issue:4 Topics: Amino Acids, Branched-Chain; Animals; Benzoates; Benzoic Acid; Clinical Trials as Topic; Electrocardiography; Female; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Magnesium; Male; Rats; Zinc	1998
Brain edema and portal-systemic encephalopathy. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2000, Volume: 6, Issue:4 Suppl 1 Topics: Brain; Brain Edema; Flumazenil; Glutamine; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Necrosis; Prognosis	2000
Treatment of acute hepatic encephalopathy. The Netherlands journal of medicine, 1979, Volume: 22, Issue:6 Topics: Acid-Base Imbalance; Acute Disease; Adrenal Cortex Hormones; Antacids; Anti-Bacterial Agents; Blood Coagulation Disorders; Bromocriptine; Cimetidine; Critical Care; Cross Circulation; Diuretics, Osmotic; Exchange Transfusion, Whole Blood; Extracorporeal Circulation; Gastrointestinal Hemorrhage; Hemoperfusion; Hepatic Encephalopathy; Hepatitis B Antibodies; Humans; Lactulose; Levodopa; Liver Circulation; Liver Transplantation; Neomycin; Parenteral Nutrition; Peritoneal Dialysis; Plasma; Renal Dialysis; Serum Albumin; Transplantation, Homologous	1979
Some aspects of medical management of gastrointestinal disease. I. Canadian Medical Association journal, 1975, Jan-25, Volume: 112, Issue:2 Topics: Diarrhea; Disaccharides; Endoscopy; Esophagitis; Gastric Juice; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Motility; Hepatic Encephalopathy; Histamine H1 Antagonists; Humans; Hypokalemia; Intubation, Gastrointestinal; Lactulose; Metoclopramide; Peptic Ulcer; Secretory Rate; Vomiting	1975
[Hepatic coma--causes, recognition, treatment]. Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1977, Jun-15, Volume: 32, Issue:12 Topics: Anti-Bacterial Agents; Coenzyme A; Exchange Transfusion, Whole Blood; Glucocorticoids; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver; Liver Circulation; Liver Function Tests; Liver Regeneration; Perfusion; Plasmapheresis	1977
Hepatic encephalopathy. Gastroenterology, 1979, Volume: 76, Issue:1 Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Brain Edema; Cathartics; Cerebrospinal Fluid Proteins; Diet Therapy; Dietary Carbohydrates; Dietary Proteins; Electroencephalography; Enema; Female; Hepatic Encephalopathy; Humans; Hypoglycemia; Intracranial Pressure; Lactulose; Levodopa; Liver Function Tests; Middle Aged; Prognosis	1979
[Exogenous hepatic coma--standard therapy with amino acid solutions]. Beitrage zu Infusionstherapie und klinische Ernahrung, 1979, Issue:4 Topics: Alkalosis; Amino Acids; Cimetidine; Energy Intake; Fluid Therapy; Hepatic Encephalopathy; Humans; Lactulose; Male; Mineralocorticoid Receptor Antagonists; Neomycin; Water-Electrolyte Imbalance	1979
[Internal therapy of portal hypertension]. Verhandlungen der Deutschen Gesellschaft fur Innere Medizin, 1976, Volume: 82 Pt 1 Topics: Anti-Bacterial Agents; Ascites; Bed Rest; Cathartics; Dietary Proteins; Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Hypersplenism; Hypertension, Portal; Hypokalemia; Lactulose; Life Expectancy; Water-Electrolyte Balance	1976
Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis. Hepatology (Baltimore, Md.), 1992, Volume: 15, Issue:2 Topics: Chronic Disease; Clinical Trials as Topic; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Meta-Analysis as Topic; Methods; Research Design; Sugar Alcohols	1992
The treatment of chronic hepatic encephalopathy. Hepato-gastroenterology, 1991, Volume: 38, Issue:5 Topics: Amantadine; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Liver Cirrhosis; Receptors, GABA-A	1991
Role of nutrition in hepatic encephalopathy. Seminars in liver disease, 1991, Volume: 11, Issue:4 Topics: Ammonia; Diet; Diet Therapy; Dietary Proteins; Enteral Nutrition; Fatty Acids, Nonesterified; Hepatic Encephalopathy; Humans; Lactulose; Nutrition Disorders; Parenteral Nutrition; Tryptophan	1991
Hepatic encephalopathy. The New England journal of medicine, 1985, Oct-03, Volume: 313, Issue:14 Topics: Ammonia; Animals; Blood-Brain Barrier; Brain; Demyelinating Diseases; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypernatremia; Hyponatremia; Ketoglutaric Acids; Lactulose; Methionine; Neomycin; Pons; Synaptic Transmission; Tryptophan	1985
[Therapy of hepatic encephalopathy]. Deutsche medizinische Wochenschrift (1946), 1988, Dec-02, Volume: 113, Issue:48 Topics: Amino Acids, Branched-Chain; Benzoates; Benzoic Acid; Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Lactulose; Phenylacetates; Zinc	1988
Chronic portal systemic encephalopathy: update 1987. Gut, 1987, Volume: 28, Issue:8 Topics: Amino Acids; Hepatic Encephalopathy; Humans; Lactulose	1987
Branched chain amino acid therapy in liver disease. Journal of the American College of Nutrition, 1985, Volume: 4, Issue:6 Topics: Administration, Oral; Amino Acids; Amino Acids, Branched-Chain; Dietary Proteins; Glucose; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Neomycin; Nitrogen; Nutrition Disorders; Parenteral Nutrition	1985
[Advances in the treatment of liver disease]. Wiener medizinische Wochenschrift (1946), 1973, Oct-06, Issue:40 Topics: Amino Acids; Anti-Bacterial Agents; Chronic Disease; Dihydroxyphenylalanine; Enzyme Induction; Exchange Transfusion, Whole Blood; gamma-Globulins; Hepatic Encephalopathy; Hepatitis; Hepatitis A; Humans; Immunosuppressive Agents; Lactulose; Liver Diseases; Peritoneal Dialysis	1973
Hepatic coma in cirrhosis, portal hypertension, and following portacaval shunt. Its etiologies and the current status of its treatment. Archives of surgery (Chicago, Ill. : 1960), 1974, Volume: 108, Issue:3 Topics: Acute Disease; Amino Acids; Ammonia; Brain; Chronic Disease; Colon; Dietary Proteins; Fatty Acids; Glutamine; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Neomycin; Neurotransmitter Agents; Portacaval Shunt, Surgical; Postoperative Complications; Sterilization; Urease	1974
Recognition and management of acute and chronic hepatic encephalopathy. The Medical clinics of North America, 1973, Volume: 57, Issue:6 Topics: Acute Disease; Amines; Ammonia; Animals; Brain Edema; Central Nervous System; Chronic Disease; Diet Therapy; Dihydroxyphenylalanine; Exchange Transfusion, Whole Blood; Fatty Acids, Volatile; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Renal Dialysis	1973
Hepatic encephalopathy: current status. Gastroenterology, 1974, Volume: 66, Issue:1 Topics: Adrenal Cortex Hormones; Amino Acids; Ammonia; Animals; Anti-Bacterial Agents; Biogenic Amines; Dihydroxyphenylalanine; Diuretics; Energy Metabolism; Exchange Transfusion, Whole Blood; Fatty Acids; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Intestines; Lactulose; Liver Diseases; Neurologic Manifestations; Oxygen Consumption; Portacaval Shunt, Surgical	1974
[Emergency treatment of hepatic coma and porto-caval encephalopathy]. Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg, 1973, Volume: 110, Issue:2 Topics: Acidosis; Alkalosis; Ammonia; Anti-Bacterial Agents; Brain Diseases; Diuretics; Emergencies; Glucose; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	1973

Trials

79 trial(s) available for lactulose and Encephalopathy, Hepatic

Article	Year
L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial. Hepatology (Baltimore, Md.), 2022, Volume: 75, Issue:5 Topics: Ammonia; Aspartic Acid; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Rifaximin; Tumor Necrosis Factor-alpha	2022
Dosing of Rifaximin Soluble Solid Dispersion Tablets in Adults With Cirrhosis: 2 Randomized, Placebo-controlled Trials. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:3 Topics: Adult; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin; Tablets	2023
Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments. Journal of hepatology, 2023, Volume: 79, Issue:2 Topics: Ammonia; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Liver Cirrhosis; Male; Phenylbutyrates; Rifaximin	2023
Lactulose therapy for patients with cirrhosis, portal hypertension, and poor patient-reported outcomes: The Mi-Kristal trial. Hepatology (Baltimore, Md.), 2023, 10-01, Volume: 78, Issue:4 Topics: Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Middle Aged; Patient Reported Outcome Measures; Quality of Life; Treatment Outcome	2023
Clinical study of probiotics combined with lactulose for minimal hepatic encephalopathy treatment. European journal of gastroenterology & hepatology, 2023, 07-01, Volume: 35, Issue:7 Topics: Ammonia; Glycation End Products, Advanced; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Probiotics	2023
Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial. Journal of digestive diseases, 2019, Volume: 20, Issue:10 Topics: Adult; Cognition; Female; Gastrointestinal Agents; Gastrointestinal Microbiome; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Quality of Life; Time Factors; Treatment Outcome	2019
Combined PEG3350 Plus Lactulose Results in Early Resolution of Hepatic Encephalopathy and Improved 28-Day Survival in Acute-on-Chronic Liver Failure. Journal of clinical gastroenterology, 2022, 01-01, Volume: 56, Issue:1 Topics: Acute-On-Chronic Liver Failure; End Stage Liver Disease; Hepatic Encephalopathy; Humans; Lactulose; Polyethylene Glycols; Severity of Illness Index; Treatment Outcome	2022
Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021, Volume: 19, Issue:12 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Ornithine; Treatment Outcome	2021
Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled t BMJ open gastroenterology, 2020, Volume: 7, Issue:1 Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Portasystemic Shunt, Transjugular Intrahepatic; Quality of Life; Rifaximin	2020
Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2021, Volume: 40, Issue:6 Topics: Acute Disease; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Treatment Outcome	2021
Is Lactulose Plus Rifaximin Better than Lactulose Alone in the Management of Hepatic Encephalopathy? Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:2 Topics: Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure; Male; Middle Aged; Rifamycins; Rifaximin; Treatment Outcome	2018
A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy. Journal of clinical gastroenterology, 2019, Volume: 53, Issue:3 Topics: Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Nitro Compounds; Thiazoles; Treatment Outcome	2019
Evaluation of the cost-effectiveness of rifaximin-α for the management of patients with hepatic encephalopathy in the United Kingdom. Current medical research and opinion, 2018, Volume: 34, Issue:11 Topics: Cost Savings; Cost-Benefit Analysis; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Quality of Life; Quality-Adjusted Life Years; Rifaximin; Secondary Prevention; United Kingdom	2018
Primary Prophylaxis to Prevent the Development of Hepatic Encephalopathy in Cirrhotic Patients with Acute Variceal Bleeding. Canadian journal of gastroenterology & hepatology, 2018, Volume: 2018 Topics: Acute Disease; Adult; Dipeptides; Double-Blind Method; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Rifaximin	2018
Randomized controlled trial of polyethylene glycol versus lactulose for the treatment of overt hepatic encephalopathy. European journal of gastroenterology & hepatology, 2018, Volume: 30, Issue:12 Topics: Adult; Aged; Female; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Lactulose; Length of Stay; Male; Middle Aged; Polyethylene Glycols; Severity of Illness Index; Treatment Outcome	2018
A Randomized Controlled Trial Comparing the Efficacy of a Combination of Rifaximin and Lactulose with Lactulose only in the Treatment of Overt Hepatic Encephalopathy. The Journal of the Association of Physicians of India, 2018, Volume: 66, Issue:1 Topics: Adult; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Rifaximin	2018
Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy. Digestive diseases (Basel, Switzerland), 2019, Volume: 37, Issue:2 Topics: Adult; Aged; Anti-Bacterial Agents; Cohort Studies; Feces; Female; Gastrointestinal Microbiome; Hepatic Encephalopathy; Humans; Intestine, Small; Lactulose; Male; Middle Aged; Phylogeny; Principal Component Analysis; Rifamycins; Rifaximin; Time Factors	2019
Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis. Gastroenterology, 2019, Volume: 156, Issue:6 Topics: Anti-Bacterial Agents; Cognition; Fecal Microbiota Transplantation; Follow-Up Studies; Gastrointestinal Agents; Gastrointestinal Microbiome; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Liver Cirrhosis; Patient Selection; Rifaximin; Stroop Test; Time Factors	2019
Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:7 Topics: Adolescent; Adult; Aged; Ammonia; Biomarkers; Endotoxins; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inflammation Mediators; Interleukin-18; Interleukin-6; Lactulose; Liver Cirrhosis; Magnetic Resonance Spectroscopy; Male; Middle Aged; Tumor Necrosis Factor-alpha; Young Adult	2013
Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. Digestion, 2013, Volume: 87, Issue:2 Topics: Adult; Aged; Ammonia; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Treatment Outcome	2013
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. The American journal of gastroenterology, 2013, Volume: 108, Issue:9 Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Length of Stay; Male; Middle Aged; Rifamycins; Rifaximin; Severity of Illness Index; Treatment Outcome	2013
Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2013, Volume: 14, Issue:3 Topics: Adult; Ammonia; Brain; Choline; Creatinine; Female; Gastrointestinal Agents; Gastrointestinal Tract; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Inositol; Lactobacillus acidophilus; Lactulose; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Probiotics	2013
Probiotics prevent hepatic encephalopathy in patients with cirrhosis: a randomized controlled trial. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2014, Volume: 12, Issue:6 Topics: Adolescent; Adult; Aged; Breath Tests; Female; Glucose; Hepatic Encephalopathy; Humans; India; Lactulose; Liver Cirrhosis; Male; Middle Aged; Probiotics; Prospective Studies; Psychometrics; Severity of Illness Index; Tertiary Care Centers; Treatment Outcome; Young Adult	2014
[Hepatic encephalopathy -- preventative effects of lactulose]. Zeitschrift fur Gastroenterologie, 2013, Volume: 51, Issue:8 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Prevalence; Risk Factors; Treatment Outcome	2013
Lactulose vs polyethylene glycol 3350--electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA internal medicine, 2014, Volume: 174, Issue:11 Topics: Aged; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Surface-Active Agents; Treatment Outcome	2014
Evaluation of rifaximin in management of hepatic encephalopathy. Journal of the Egyptian Society of Parasitology, 2014, Volume: 44, Issue:3 Topics: Adult; Anti-Infective Agents; Enema; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Rifamycins; Rifaximin	2014
Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy. Liver international : official journal of the International Association for the Study of the Liver, 2016, Volume: 36, Issue:3 Topics: Adult; Aged; Cognition; Female; Hepatic Encephalopathy; Humans; India; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychometrics; Quality of Life; Rifamycins; Rifaximin; Sickness Impact Profile; Time Factors; Treatment Outcome	2016
RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial. Trials, 2016, Feb-29, Volume: 17, Issue:1 Topics: Anti-Infective Agents; Clinical Protocols; Drug Therapy, Combination; Duodenum; Electroencephalography; Endoscopy, Gastrointestinal; Evoked Potentials, Visual; Flicker Fusion; Gastrointestinal Microbiome; Germany; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Pilot Projects; Psychometrics; Research Design; Rifamycins; Rifaximin; Stomach; Time Factors; Treatment Outcome	2016
Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. Journal of gastroenterology and hepatology, 2017, Volume: 32, Issue:6 Topics: Adult; Albumins; Ammonia; Biomarkers; Drug Therapy, Combination; Endotoxins; Female; Hepatic Encephalopathy; Humans; Interleukin-18; Interleukin-6; Lactulose; Male; Middle Aged; Prospective Studies; Treatment Outcome; Tumor Necrosis Factor-alpha	2017
Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology, 2009, Volume: 137, Issue:3 Topics: Adult; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Psychometrics; Secondary Prevention	2009
Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:2 Topics: Adult; Ammonia; Bifidobacterium; Cognition; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Oligosaccharides; Prebiotics; Probiotics; Psychometrics; Time Factors; Treatment Outcome	2010
Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:5 Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Chronic Disease; Drug Resistance; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypertension, Portal; Hyponatremia; Lactulose; Leukocyte Count; Liver Cirrhosis; Liver Failure; Liver Neoplasms; Male; Middle Aged; Predictive Value of Tests; Young Adult	2010
Rifaximin treatment in hepatic encephalopathy. The New England journal of medicine, 2010, Mar-25, Volume: 362, Issue:12 Topics: Aged; Anti-Infective Agents; Chronic Disease; Clostridioides difficile; Clostridium Infections; Double-Blind Method; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Rifamycins; Rifaximin; Secondary Prevention	2010
Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:6 Topics: Acute Disease; Adult; Blood Transfusion; Chi-Square Distribution; Esophageal and Gastric Varices; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; India; Lactulose; Liver Cirrhosis; Male; Middle Aged; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Young Adult	2011
A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy. European journal of gastroenterology & hepatology, 2011, Volume: 23, Issue:8 Topics: Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Quality of Life; Severity of Illness Index; Treatment Outcome	2011
Efficacy of L-ornithine-L-aspartate as an adjuvant therapy in cirrhotic patients with hepatic encephalopathy. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2011, Volume: 21, Issue:11 Topics: Anti-Infective Agents; Dipeptides; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Glucose; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Lactulose; Length of Stay; Liver Cirrhosis; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome	2011
Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:8 Topics: Adult; Chi-Square Distribution; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; India; Lactulose; Linear Models; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Primary Prevention; Psychometrics; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2012
Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy. The American journal of gastroenterology, 2012, Volume: 107, Issue:7 Topics: Adolescent; Adult; Aged; Ammonia; Analysis of Variance; Chi-Square Distribution; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Secondary Prevention; Statistics, Nonparametric; Treatment Outcome	2012
[Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy]. Zhonghua nei ke za zhi, 2003, Volume: 42, Issue:4 Topics: Adult; Aged; Ammonia; Evoked Potentials, Somatosensory; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intelligence Tests; Lactulose; Male; Middle Aged; Treatment Outcome	2003
[Effects of lactulose treatment on the course of subclinical hepatic encephalopathy]. Zhonghua yi xue za zhi, 2003, Jul-10, Volume: 83, Issue:13 Topics: Administration, Oral; Adult; Aged; Ammonia; Evoked Potentials, Somatosensory; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Function Tests; Male; Middle Aged; Quality of Life; Time Factors; Treatment Outcome	2003
Changes in brain size in hepatic encephalopathy: a coregistered MRI study. Metabolic brain disease, 2004, Volume: 19, Issue:3-4 Topics: Aged; Brain; Brain Edema; Cohort Studies; Disease Progression; Female; Hepatic Encephalopathy; Humans; Lactulose; Lateral Ventricles; Liver Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Portasystemic Shunt, Surgical; Predictive Value of Tests; Reproducibility of Results; Treatment Outcome	2004
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. Yonsei medical journal, 2005, Jun-30, Volume: 46, Issue:3 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Prospective Studies; Rifamycins; Rifaximin; Treatment Outcome	2005
Analysis of hospitalizations comparing rifaximin versus lactulose in the management of hepatic encephalopathy. Transplantation proceedings, 2006, Volume: 38, Issue:10 Topics: Adult; Costs and Cost Analysis; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Length of Stay; Liver Failure; Liver Transplantation; Male; Middle Aged; Pilot Projects; Postoperative Complications; Retrospective Studies; Rifamycins; Rifaximin	2006
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:3 Topics: Activities of Daily Living; Adult; Aged; Cognition; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Multivariate Analysis; Neuropsychological Tests; Psychometrics; Psychomotor Performance; Quality of Life; Sickness Impact Profile	2007
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. European journal of gastroenterology & hepatology, 2008, Volume: 20, Issue:6 Topics: Adult; Ammonia; Drug Therapy, Combination; Event-Related Potentials, P300; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neuropsychological Tests; Probiotics; Psychometrics; Severity of Illness Index; Treatment Outcome	2008
Progress in the treatment of chronic portasystemic encephalopathy. Gut, 1984, Volume: 25, Issue:1 Topics: Amino Acids, Branched-Chain; Ammonia; Animals; Bromocriptine; Chronic Disease; Clinical Trials as Topic; Colon; Dietary Proteins; Dogs; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Keto Acids; Lactulose; Levodopa; Metronidazole; Neomycin	1984
Branched-chain amino acids vs lactulose in the treatment of hepatic coma: a controlled study. Digestive diseases and sciences, 1982, Volume: 27, Issue:10 Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Clinical Trials as Topic; Disaccharides; Glucose; Hepatic Encephalopathy; Humans; Infusions, Parenteral; Lactulose; Liver Cirrhosis	1982
Comparison between neomycin and lactulose in 173 patients with hepatic encephalopathy: a randomized clinical study. Digestive diseases and sciences, 1981, Volume: 26, Issue:6 Topics: Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neomycin; Random Allocation	1981
Therapy of portal-systemic encephalopathy: the practical and the promising. Gastroenterology, 1981, Volume: 81, Issue:1 Topics: Amino Acids; Ammonia; Bacteria; Enema; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Neomycin	1981
Rifaximin in the treatment of chronic hepatic encephalopathy. Current medical research and opinion, 1995, Volume: 13, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Ammonia; Analysis of Variance; Anti-Bacterial Agents; Chronic Disease; Drug Synergism; Drug Therapy, Combination; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Rifamycins; Rifaximin; Time Factors; Treatment Outcome	1995
Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study. Zhonghua yi xue za zhi = Chinese medical journal; Free China ed, 1995, Volume: 55, Issue:1 Topics: Aged; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Sugar Alcohols	1995
[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:12 Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Placebos	1994
[Effects of neomycin on intestinal digestion, absorption and fermentation of carbohydrates in patients with liver cirrhosis: evidence for an alternative therapeutic mechanism in hepatic encephalopathy]. Revista medica de Chile, 1994, Volume: 122, Issue:4 Topics: Carbohydrate Metabolism; Digestion; Female; Fermentation; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactose; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Time Factors; Xylose	1994
Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy. Current medical research and opinion, 1993, Volume: 13, Issue:2 Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Rifamycins; Rifaximin	1993
Lactitol in treatment of chronic hepatic encephalopathy. A meta-analysis. Digestive diseases and sciences, 1993, Volume: 38, Issue:5 Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols; Treatment Outcome	1993
Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. Journal of hepatology, 1995, Volume: 23, Issue:1 Topics: Adult; Aged; Ammonia; Dose-Response Relationship, Drug; Double-Blind Method; Enterococcus faecium; Evoked Potentials, Visual; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Severity of Illness Index; Time Factors	1995
Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. Alimentary pharmacology & therapeutics, 1997, Volume: 11, Issue:1 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Psychiatric Status Rating Scales	1997
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:6 Topics: Administration, Oral; Adult; Aged; Ammonia; Cathartics; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Wechsler Scales	1997
Diagnosis of hepatic encephalopathy: will in vivo proton MRS play a role? Hepatology (Baltimore, Md.), 1999, Volume: 29, Issue:5 Topics: Administration, Oral; Brain; Hepatic Encephalopathy; Humans; Lactulose; Magnetic Resonance Imaging	1999
Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. Digestive diseases and sciences, 2000, Volume: 45, Issue:8 Topics: Adult; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Psychological Tests; Treatment Outcome	2000
[The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis]. Klinicheskaia meditsina, 2002, Volume: 80, Issue:5 Topics: Adult; Dipeptides; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged	2002
Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology, 1977, Volume: 72, Issue:4 Pt 1 Topics: Aged; Ammonia; Blood; Chronic Disease; Clinical Trials as Topic; Disaccharides; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Mental Processes; Middle Aged; Neomycin; Prospective Studies; Sorbitol; Trail Making Test	1977
Effect of vegetable and animal protein diets in chronic hepatic encephalopathy. The American journal of digestive diseases, 1977, Volume: 22, Issue:10 Topics: Adult; Amino Acids; Chronic Disease; Clinical Trials as Topic; Dietary Proteins; Female; Hepatic Encephalopathy; Humans; Intelligence Tests; Lactulose; Liver Cirrhosis; Liver Function Tests; Male; Meat; Methionine; Middle Aged; Plant Proteins, Dietary; Proteins	1977
Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. The American journal of digestive diseases, 1978, Volume: 23, Issue:5 Topics: Clinical Trials as Topic; Disaccharides; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Neomycin; Placebos; Sorbitol	1978
[Changes in the levels of ammonia and free phenols in patients with portocaval shunt treated with lactulose and/or neomycin compared to a low protein diet (author's transl)]. Medizinische Klinik, 1978, Jan-13, Volume: 73, Issue:2 Topics: Ammonia; Dietary Proteins; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Phenols; Portacaval Shunt, Surgical	1978
Lactulose for hepatic encephalopathy. The Medical letter on drugs and therapeutics, 1976, Jan-02, Volume: 18, Issue:1 Topics: Clinical Trials as Topic; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose	1976
The effect of lactulose and lactitol administration on fecal fat excretion in patients with liver cirrhosis. Journal of clinical gastroenterology, 1992, Volume: 15, Issue:2 Topics: Adult; Aged; Feces; Hepatic Encephalopathy; Humans; Intestinal Absorption; Lactulose; Lipid Metabolism; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols	1992
Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial. Hepatology (Baltimore, Md.), 1992, Volume: 16, Issue:1 Topics: Acute Disease; Adult; Benzoates; Benzoic Acid; Brain; Double-Blind Method; Electroencephalography; Evoked Potentials; Female; Hepatic Encephalopathy; Humans; Intelligence; Lactulose; Male; Memory; Prospective Studies; Psychometrics	1992
Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy. Gut, 1990, Volume: 31, Issue:6 Topics: Ammonia; Bacteria; Disaccharides; Double-Blind Method; Drug Resistance; Electroencephalography; Feces; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Randomized Controlled Trials as Topic; Vancomycin	1990
Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose. Hepato-gastroenterology, 1990, Volume: 37, Issue:5 Topics: Adult; Aged; Chronic Disease; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Sugar Alcohols	1990
Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. Journal of hepatology, 1989, Volume: 8, Issue:2 Topics: Clinical Trials as Topic; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Psychological Tests; Random Allocation; Sugar Alcohols	1989
Lactitol in prevention of recurrent episodes of hepatic encephalopathy in cirrhotic patients with portal-systemic shunt. Digestive diseases and sciences, 1989, Volume: 34, Issue:6 Topics: Adolescent; Adult; Amino Acids; Clinical Trials as Topic; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Surgical; Random Allocation; Recurrence; Sugar Alcohols	1989
Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy. Journal of hepatology, 1988, Volume: 7, Issue:1 Topics: Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Neuropsychological Tests; Recurrence; Sugar Alcohols	1988
[Therapy of hepatic encephalopathy]. Deutsche medizinische Wochenschrift (1946), 1988, Dec-02, Volume: 113, Issue:48 Topics: Amino Acids, Branched-Chain; Benzoates; Benzoic Acid; Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Lactulose; Phenylacetates; Zinc	1988
Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study. Journal of hepatology, 1987, Volume: 4, Issue:2 Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Disaccharides; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Random Allocation; Sugar Alcohols	1987
Comparative modes of action of lactitol and lactulose in the treatment of hepatic encephalopathy. Gut, 1987, Volume: 28, Issue:3 Topics: Colon; Disaccharides; Fatty Acids, Volatile; Feces; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Neomycin; Sugar Alcohols	1987
Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial. Journal of hepatology, 1987, Volume: 4, Issue:3 Topics: Acute Disease; Adult; Aged; Bacterial Infections; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Sugar Alcohols	1987
Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol. The American journal of gastroenterology, 1973, Volume: 60, Issue:5 Topics: Aged; Chronic Disease; Clinical Trials as Topic; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Sorbitol	1973
[Dilemmas of clinical experimentation: use of lactulose in portocaval encephalopathy]. L'union medicale du Canada, 1974, Volume: 103, Issue:12 Topics: Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Placebos; Research Design; Sorbitol; Time Factors	1974

Other Studies

209 other study(ies) available for lactulose and Encephalopathy, Hepatic

Article	Year
Primary Prophylaxis Patterns for Hepatic Encephalopathy in Patients with Liver Cirrhosis: What are the Current Prescribing Trends in Specialty Practice? The Journal of the Association of Physicians of India, 2021, Volume: 69, Issue:8 Topics: Cross-Sectional Studies; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	2021
An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis. The American journal of gastroenterology, 2022, 03-01, Volume: 117, Issue:3 Topics: Drug Therapy, Combination; Electronics; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Patient Readmission; Rifaximin	2022
Polyethylene Glycol Versus Lactulose for Hepatic Encephalopathy: Do We Have a Clear Winner? Journal of clinical gastroenterology, 2022, 02-01, Volume: 56, Issue:2 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Polyethylene Glycols	2022
Rate of Successful Extubation in Mechanically Ventilated Patients with Cirrhosis and Hepatic Coma. Digestive diseases and sciences, 2022, Volume: 67, Issue:11 Topics: Airway Extubation; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Prospective Studies; Respiration, Artificial; Respiratory Insufficiency; Retrospective Studies; Rifaximin	2022
Editorial: infections and hepatic encephalopathy-does the chicken or the egg come FIRST? A novel perspective at the horizon. Alimentary pharmacology & therapeutics, 2022, Volume: 55, Issue:6 Topics: Hepatic Encephalopathy; Humans; Lactulose; Rifaximin	2022
Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States. Journal of hepatology, 2022, Volume: 77, Issue:2 Topics: Aged; Ethnicity; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Medicare; Referral and Consultation; Rifaximin; United States	2022
Lack of Access to Rifaximin Upon Hospital Discharge Is Frequent and Results in Increased Hospitalizations for Hepatic Encephalopathy. The Annals of pharmacotherapy, 2023, Volume: 57, Issue:2 Topics: Drug Therapy, Combination; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Hospitals; Humans; Lactulose; Liver Cirrhosis; Patient Discharge; Retrospective Studies; Rifamycins; Rifaximin	2023
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy. Internal medicine (Tokyo, Japan), 2023, Apr-01, Volume: 62, Issue:7 Topics: Ammonia; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin	2023
Gut metagenome-derived signature predicts hepatic decompensation and mortality in NAFLD-related cirrhosis. Alimentary pharmacology & therapeutics, 2022, Volume: 56, Issue:10 Topics: Adult; Ascites; End Stage Liver Disease; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Metagenome; Non-alcoholic Fatty Liver Disease; Prospective Studies; Rifaximin; Severity of Illness Index	2022
Clinical Outcomes of Oral Zinc Therapy in Hepatic Encephalopathy Treatment. The Annals of pharmacotherapy, 2023, Volume: 57, Issue:8 Topics: Drug Therapy, Combination; End Stage Liver Disease; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Retrospective Studies; Rifamycins; Rifaximin; Severity of Illness Index; Zinc	2023
Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy. Digestive diseases and sciences, 2023, Volume: 68, Issue:6 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Liver Cirrhosis	2023
Ammonia - an enduring foe - What evaluating whole body ammonia metabolism can teach us about cirrhosis and therapies treating hepatic encephalopathy. Journal of hepatology, 2023, Volume: 79, Issue:2 Topics: Ammonia; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin	2023
The PROs and cons of crystalline lactulose for suspected covert HE among patients with cirrhosis and activity impairment: Are we using the right assessments? Hepatology (Baltimore, Md.), 2023, 10-01, Volume: 78, Issue:4 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	2023
Lactulose in cirrhosis: Current understanding of efficacy, mechanism, and practical considerations. Hepatology communications, 2023, 11-01, Volume: 7, Issue:11 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Quality of Life	2023
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nature microbiology, 2023, Volume: 8, Issue:11 Topics: Animals; Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Mice	2023
A specialized HE testing clinic improves rational decision-making for therapy in cirrhosis. Hepatology communications, 2023, Nov-01, Volume: 7, Issue:11 Topics: End Stage Liver Disease; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Severity of Illness Index; Sleep Apnea, Obstructive	2023
Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection. Digestive diseases and sciences, 2020, Volume: 65, Issue:2 Topics: Aged; Anti-Bacterial Agents; Chemoprevention; Clostridioides difficile; Clostridium Infections; Diarrhea; End Stage Liver Disease; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intensive Care Units; Lactulose; Liver Cirrhosis; Male; Middle Aged; Mortality; Retrospective Studies; Rifaximin; Severity of Illness Index	2020
Lactulose drives a reversible reduction and qualitative modulation of the faecal microbiota diversity in healthy dogs. Scientific reports, 2019, 09-16, Volume: 9, Issue:1 Topics: Animals; Bacteria; Biodiversity; DNA, Bacterial; Dogs; Dysbiosis; Feces; Female; Gastrointestinal Agents; Gastrointestinal Microbiome; Hepatic Encephalopathy; High-Throughput Nucleotide Sequencing; Lactulose; Male; Prospective Studies; RNA, Ribosomal, 16S	2019
Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. The American journal of gastroenterology, 2020, Volume: 115, Issue:5 Topics: Ammonia; Biomarkers; Disease Management; Female; Follow-Up Studies; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Inpatients; Lactulose; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Treatment Outcome	2020
Identifying Patients With Hepatic Encephalopathy Using Administrative Data in the ICD-10 Era. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2021, Volume: 19, Issue:3 Topics: Algorithms; Child; Databases, Factual; Hepatic Encephalopathy; Humans; International Classification of Diseases; Lactulose; Rifaximin	2021
Management of hepatic encephalopathy in Germany: a survey among physicians. Zeitschrift fur Gastroenterologie, 2020, Volume: 58, Issue:1 Topics: Disease Management; Gastroenterologists; Gastrointestinal Agents; General Practitioners; Germany; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Practice Patterns, Physicians'; Quality of Life; Rifaximin; Secondary Prevention; Surveys and Questionnaires	2020
A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis. The American journal of medicine, 2020, Volume: 133, Issue:10 Topics: Aged; Brain; Confusion; Dyskinesias; Esophageal and Gastric Varices; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Hyperbilirubinemia; Hypertension, Portal; Lactulose; Liver Cirrhosis; Magnetic Resonance Imaging; Male; Non-alcoholic Fatty Liver Disease; Renal Veins; Rifaximin; Splenic Vein; Thrombocytopenia; Tomography, X-Ray Computed; Tremor; Vascular Diseases	2020
Hepatic encephalopathy: a rare cause of focal seizures in chronic liver disease. BMJ case reports, 2020, Mar-12, Volume: 13, Issue:3 Topics: Aftercare; Anticonvulsants; Chronic Disease; Diagnosis, Differential; Electroencephalography; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases; Magnetic Resonance Imaging; Middle Aged; Rifaximin; Seizures; Treatment Outcome	2020
A retrospective study of drug utilization and hospital readmissions among Medicare patients with hepatic encephalopathy. Medicine, 2020, Volume: 99, Issue:16 Topics: Administrative Claims, Healthcare; Aged; Aged, 80 and over; Ambulatory Care; Anti-Bacterial Agents; Drug Prescriptions; Drug Therapy, Combination; Female; Follow-Up Studies; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Medicare Part C; Medication Adherence; Middle Aged; Neomycin; Patient Readmission; Recurrence; Retrospective Studies; Rifaximin; United States	2020
Small Intestinal Bacterial Overgrowth Diagnosed by a Breath Test and Improved by Rifaximin in a Patient with Hepatic Encephalopathy and Alcoholic Liver Cirrhosis. Internal medicine (Tokyo, Japan), 2020, Aug-01, Volume: 59, Issue:15 Topics: Aged; Amino Acids, Branched-Chain; Anti-Bacterial Agents; Blind Loop Syndrome; Breath Tests; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis, Alcoholic; Male; Rifaximin	2020
Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy. Journal of managed care & specialty pharmacy, 2020, Volume: 26, Issue:6 Topics: Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Hepatic Encephalopathy; Hospitalization; Humans; Incidence; Lactulose; Liver Cirrhosis; Liver Transplantation; Maintenance Chemotherapy; Markov Chains; Models, Economic; Quality of Life; Quality-Adjusted Life Years; Recurrence; Rifaximin; Secondary Prevention	2020
Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. World journal of gastroenterology, 2020, May-14, Volume: 26, Issue:18 Topics: Aged; Clinical Decision-Making; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Kaplan-Meier Estimate; Lactulose; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Patient Selection; Prognosis; Retrospective Studies; Rifaximin; Severity of Illness Index; Standard of Care; Treatment Outcome	2020
Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy. Journal of hepatology, 2021, Volume: 74, Issue:1 Topics: Brain-Gut Axis; Correlation of Data; Cross-Sectional Studies; End Stage Liver Disease; Female; Gastrointestinal Agents; Gastrointestinal Microbiome; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Rifaximin; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Sex Factors	2021
Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis. The American journal of gastroenterology, 2021, 02-01, Volume: 116, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Anti-Bacterial Agents; Ascites; beta-Lactams; Clinical Decision Rules; Cohort Studies; End Stage Liver Disease; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hydrothorax; Infections; Kidney Diseases; Lactulose; Liver Cirrhosis; Logistic Models; Machine Learning; Male; Middle Aged; Mortality; Paracentesis; Patient Readmission; Proton Pump Inhibitors; Reproducibility of Results; Rifaximin; ROC Curve; Severity of Illness Index; Support Vector Machine; Water-Electrolyte Imbalance	2021
Use of Lactulose in Hepatic Encephalopathy: Is It Time to Shift Targets? Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2022, Volume: 20, Issue:5 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	2022
Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-α. European journal of gastroenterology & hepatology, 2021, 12-01, Volume: 33, Issue:1S Suppl 1 Topics: Europe; Hepatic Encephalopathy; Humans; Lactulose; Quality of Life; Rifamycins; Rifaximin	2021
A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis. Digestive diseases and sciences, 2017, Volume: 62, Issue:8 Topics: Acute Kidney Injury; Constipation; Dehydration; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Liver Cirrhosis; Male; Medication Adherence; Middle Aged; Prospective Studies; Retrospective Studies; Safety-net Providers; Severity of Illness Index	2017
Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy. The Journal of the Association of Physicians of India, 2017, Volume: 65, Issue:8 Topics: Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Prospective Studies; Rifamycins; Rifaximin	2017
Safe and effective administration of lactulose retention enema in the ED using specialized rectal medication administration catheter. The American journal of emergency medicine, 2018, Volume: 36, Issue:3 Topics: Administration, Rectal; Catheters; Emergency Service, Hospital; Enema; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged	2018
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy. Alimentary pharmacology & therapeutics, 2017, Volume: 46, Issue:9 Topics: Aged; Anti-Infective Agents; Bacterial Infections; Carcinoma, Hepatocellular; Esophageal and Gastric Varices; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Peritonitis; Recurrence; Retrospective Studies; Rifamycins; Rifaximin; Secondary Prevention	2017
Lactulose enemas in the treatment of hepatic encephalopathy. Do we help or harm? Revista espanola de enfermedades digestivas, 2017, Volume: 109, Issue:10 Topics: Enema; Hepatic Encephalopathy; Humans; Lactulose; Patient Safety; Phosphates	2017
Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta-analysis involving 826 patients based on 10 randomized controlled trials. Journal of cellular biochemistry, 2018, Volume: 119, Issue:10 Topics: Acetylcarnitine; Adult; Ammonia; Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Network Meta-Analysis; Neuroprotective Agents; Probiotics; Randomized Controlled Trials as Topic; Rifaximin; Serum Albumin; Treatment Outcome	2018
Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:12 Topics: Aged; Cohort Studies; Drug Therapy, Combination; End Stage Liver Disease; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Quality of Health Care; Recurrence; Rifaximin	2019
Editorial: mind the gaps - an important first step towards improving hepatic encephalopathy care. Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:12 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	2019
A patient with hemodialysis-related hyperammonemic encephalopathy: a delayed presentation of congenital arterioportal fistulas. Clinical nephrology, 2013, Volume: 79, Issue:6 Topics: Adult; Arteriovenous Fistula; Chronic Disease; Embolization, Therapeutic; Female; Gastrointestinal Agents; Hepatic Artery; Hepatic Encephalopathy; Humans; Hyperammonemia; Incidental Findings; Lactulose; Nephritis, Interstitial; Portal Vein; Renal Dialysis; Treatment Outcome	2013
Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: a realistic hope? Medical hypotheses, 2013, Volume: 81, Issue:2 Topics: Hepatic Encephalopathy; Humans; Lactulose; Models, Theoretical; Probiotics	2013
ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy. Annals of internal medicine, 2013, Oct-15, Volume: 159, Issue:8 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Rifamycins	2013
Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain. The American journal of gastroenterology, 2014, Volume: 109, Issue:4 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Rifamycins	2014
Response to Congly and Leise. The American journal of gastroenterology, 2014, Volume: 109, Issue:4 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Rifamycins	2014
[Comparative effectiveness of different treatment methods of liver failure]. Khirurgiia, 2014, Issue:3 Topics: Comparative Effectiveness Research; Dipeptides; Extracorporeal Circulation; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Failure; Male; Middle Aged; Monitoring, Physiologic; Plasma Exchange; Sorption Detoxification; Treatment Outcome	2014
[Intestine specific broad spectrum antibiotic. Rifaximin: therapy option in hepatic encephalopathy]. MMW Fortschritte der Medizin, 2014, Feb-20, Volume: 156, Issue:3 Topics: Anti-Infective Agents; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Medication Adherence; Quality of Life; Randomized Controlled Trials as Topic; Rifamycins; Rifaximin; Secondary Prevention	2014
Polyethylene glycol for hepatic encephalopathy: a new solution to purge an old problem? JAMA internal medicine, 2014, Volume: 174, Issue:11 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Polyethylene Glycols; Surface-Active Agents	2014
Liver: the gut is a key target of therapy in hepatic encephalopathy. Nature reviews. Gastroenterology & hepatology, 2015, Volume: 12, Issue:1 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intestines; Lactulose; Polyethylene Glycols; Rifamycins; Rifaximin; Treatment Outcome	2015
[Hepatic encephalopathy. Early therapy is most important!]. MMW Fortschritte der Medizin, 2014, Nov-06, Volume: 156, Issue:19 Topics: Ammonia; Anti-Bacterial Agents; Early Diagnosis; Early Medical Intervention; Hepatic Encephalopathy; Humans; Lactulose; Life Style	2014
Treatment of Acute Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes. Journal of pharmacy practice, 2016, Volume: 29, Issue:3 Topics: Acute Disease; Aged; Drug Therapy, Combination; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Length of Stay; Male; Middle Aged; Patient Outcome Assessment; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome	2016
[Acute hepatic encephalopathy: treatment by purge?]. Revue medicale suisse, 2014, Dec-03, Volume: 10, Issue:453 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Cathartics; Hepatic Encephalopathy; Humans; Lactulose; Middle Aged; Polyethylene Glycols; Randomized Controlled Trials as Topic; United States; Young Adult	2014
A gut solution for hepatic encephalopathy. Hepatology (Baltimore, Md.), 2015, Volume: 61, Issue:6 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Polyethylene Glycols; Surface-Active Agents	2015
Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy. JAMA internal medicine, 2015, Volume: 175, Issue:5 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Polyethylene Glycols; Surface-Active Agents	2015
Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy. JAMA internal medicine, 2015, Volume: 175, Issue:5 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Polyethylene Glycols; Surface-Active Agents	2015
Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply. JAMA internal medicine, 2015, Volume: 175, Issue:5 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Polyethylene Glycols; Surface-Active Agents	2015
Bispectral index monitoring for diagnosis and assessment of severity of hepatic encephalopathy in cirrhotic patients. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2015, Volume: 47, Issue:9 Topics: Adult; Ammonia; Case-Control Studies; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Psychometrics; ROC Curve; Severity of Illness Index	2015
Spontaneous portosystemic shunts in noncirrhotic patients presenting with encephalopathy. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2015, Volume: 34, Issue:3 Topics: Embolization, Therapeutic; Female; Hepatic Encephalopathy; Hepatic Veins; Humans; Lactulose; Male; Middle Aged; Portal Vein; Tomography, X-Ray Computed; Treatment Outcome	2015
[In Process Citation]. MMW Fortschritte der Medizin, 2015, Volume: 157 Suppl 2 Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Early Diagnosis; Early Medical Intervention; Evidence-Based Medicine; Hepatic Encephalopathy; Humans; Lactulose; Prognosis; Rifamycins; Rifaximin	2015
[Overt hepatic encephalopathy: extension of therapeutic armamentarium by old friends?]. Zeitschrift fur Gastroenterologie, 2015, Volume: 53, Issue:7 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Male; Polyethylene Glycols; Surface-Active Agents	2015
A Quality Improvement Initiative Reduces 30-Day Rate of Readmission for Patients With Cirrhosis. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:5 Topics: Adult; Aged; Antibiotic Prophylaxis; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Patient Readmission; Prospective Studies; Quality Improvement; Rifamycins; Rifaximin; Treatment Outcome	2016
Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Journal of gastroenterology and hepatology, 2016, Volume: 31, Issue:6 Topics: Adult; Brain; Case-Control Studies; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Predictive Value of Tests; Psychometrics; Remission Induction; Reproducibility of Results; Severity of Illness Index; Time Factors; Treatment Outcome	2016
Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy. Liver international : official journal of the International Association for the Study of the Liver, 2017, Volume: 37, Issue:2 Topics: Aged; Ammonia; Bacterial Translocation; Biomarkers; Cognition; DNA, Bacterial; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Psychometrics; Severity of Illness Index; Spain	2017
[Not Available]. Deutsche medizinische Wochenschrift (1946), 2016, Volume: 141, Issue:17 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	2016
[Hepatic encephalopathy]. Recenti progressi in medicina, 2016, Volume: 107, Issue:7 Topics: Anti-Bacterial Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Treatment Outcome	2016
Targeting the muscle for the treatment and prevention of hepatic encephalopathy. Journal of hepatology, 2016, Volume: 65, Issue:5 Topics: Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Muscles	2016
Comment on: Treatment of Acute Hepatic Encephalopathy: Comparing the Effects of Adding Rifaximin to Lactulose on Patient Outcomes. Journal of pharmacy practice, 2016, Volume: 29, Issue:6 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	2016
[Old wine in new bottles: Lactulose works in hepatic encephalopathy]. Ugeskrift for laeger, 2016, 10-17, Volume: 178, Issue:42 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	2016
Quiz Page November 2016: Kidney and Neurologic Complications in the Treatment of a Patient With Hepatic Encephalopathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2016, Volume: 68, Issue:5 Topics: Acute Kidney Injury; Adult; Alcohol Withdrawal Delirium; Brain; Diarrhea; Fluid Therapy; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypernatremia; Lactulose; Magnetic Resonance Imaging; Male; Myelinolysis, Central Pontine; Quadriplegia	2016
A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction. World journal of pediatrics : WJP, 2017, Volume: 13, Issue:1 Topics: Chi-Square Distribution; Child; Cohort Studies; Egypt; Electroencephalography; Female; Follow-Up Studies; Hepatic Encephalopathy; Hepatic Veno-Occlusive Disease; Hospitals, University; Humans; Hypertension, Portal; Lactulose; Liver Function Tests; Male; Neuropsychological Tests; Pilot Projects; Prospective Studies; Psychometrics; Risk Assessment; Severity of Illness Index; Treatment Outcome	2017
Cochrane systematic review highlights the importance of lactulose in the management of hepatic encephalopathy. BMJ supportive & palliative care, 2018, Volume: 8, Issue:2 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	2018
Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study. Digestive diseases and sciences, 2017, Volume: 62, Issue:3 Topics: Aged; Cognition; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Intelligence Tests; Italy; Lactulose; Learning Disabilities; Liver Cirrhosis; Male; Mental Competency; Middle Aged; Psychometrics; United States	2017
Sleep disturbances in patients of liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy. Metabolic brain disease, 2017, Volume: 32, Issue:2 Topics: Adult; Ammonia; Disorders of Excessive Somnolence; Female; Flicker Fusion; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Polysomnography; Psychometrics; Quality of Life; Sleep Wake Disorders; Treatment Outcome	2017
Posterior reversible encephalopathy syndrome in alcoholic hepatitis: Hepatic encephalopathy a common theme. World journal of gastroenterology, 2017, Jan-14, Volume: 23, Issue:2 Topics: Acetamides; Adult; Anticonvulsants; Ascites; Brain; Electroencephalography; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hepatitis, Alcoholic; Humans; Lacosamide; Lactulose; Liver Function Tests; Magnetic Resonance Imaging; Patient Compliance; Posterior Leukoencephalopathy Syndrome; Pregnancy; Radiography; Rifamycins; Rifaximin; Seizures; Serum Albumin	2017
'Hepatic' encephalopathy because of spontaneous mesenterico-caval shunt. Liver international : official journal of the International Association for the Study of the Liver, 2008, Volume: 28, Issue:7 Topics: Anti-Bacterial Agents; Collateral Circulation; Fatty Liver; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Mesenteric Veins; Middle Aged; Norfloxacin; Treatment Outcome; Vena Cava, Inferior	2008
Investigation of autonomic function and orocecal transit time in patients with nonalcoholic cirrhosis and the potential influence of these factors on disease outcome. Journal of clinical gastroenterology, 2009, Volume: 43, Issue:9 Topics: Adult; Autonomic Nervous System; Breath Tests; Disease Progression; Electrocardiography, Ambulatory; Female; Gastrointestinal Transit; Heart Rate; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Prognosis; Severity of Illness Index; Time Factors	2009
Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2009, Volume: 29, Issue:9 Topics: Adult; Ammonia; Event-Related Potentials, P300; Female; Flicker Fusion; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Psychometrics; Sodium	2009
Persistent portosystemic shunts after liver transplantation causing episodic hepatic encephalopathy. Digestive diseases and sciences, 2010, Volume: 55, Issue:6 Topics: Drug Therapy, Combination; Embolization, Therapeutic; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Circulation; Liver Transplantation; Male; Middle Aged; Portal System; Portography; Recurrence; Rifamycins; Rifaximin; Tomography, X-Ray Computed; Treatment Outcome; Ultrasonography, Doppler	2010
Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary & pancreatic diseases international : HBPD INT, 2010, Volume: 9, Issue:1 Topics: Adult; Case-Control Studies; Event-Related Potentials, P300; Female; Flicker Fusion; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Psychometrics; Recovery of Function	2010
Predictors of the recurrence of hepatic encephalopathy in lactulose-treated patients. Alimentary pharmacology & therapeutics, 2010, Volume: 31, Issue:9 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Patient Compliance; Recurrence; Retrospective Studies; Young Adult	2010
Gut flora and hepatic encephalopathy in patients with cirrhosis. The New England journal of medicine, 2010, Mar-25, Volume: 362, Issue:12 Topics: Ammonia; Anti-Infective Agents; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Rifamycins; Rifaximin; Secondary Prevention	2010
Reversing Hyperammonemia in Neuroendocrine Tumors. Journal of clinical gastroenterology, 2010, Volume: 44, Issue:8 Topics: Aged; Combined Modality Therapy; Fatal Outcome; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Palliative Care; Renal Dialysis; Tomography, X-Ray Computed; Treatment Outcome	2010
Rifaximin treatment in hepatic encephalopathy. The New England journal of medicine, 2010, Jun-24, Volume: 362, Issue:25 Topics: Anti-Infective Agents; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Peritonitis; Rifamycins; Rifaximin	2010
[Reduction of hospital stay with the use of L-ornithine L-aspartate (LOLA) in patients with hepatic encephalopathy]. Revista de gastroenterologia de Mexico, 2010, Volume: 75, Issue:2 Topics: Adult; Aged; Dipeptides; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Length of Stay; Male; Middle Aged; Retrospective Studies	2010
Hepatic encephalopathy and mild lack of awareness. Alimentary pharmacology & therapeutics, 2010, Volume: 32, Issue:2 Topics: Awareness; Hepatic Encephalopathy; Humans; Lactulose; Neomycin	2010
Drug therapy: rifaximin. Hepatology (Baltimore, Md.), 2010, Volume: 52, Issue:4 Topics: Clinical Trials as Topic; Female; Hepatic Encephalopathy; Humans; Lactulose; Middle Aged; Rifamycins; Rifaximin	2010
[Acute liver injury with hepatic encephalopathy associated with gemcitabine administration for adjuvant chemotherapy in an HBV carrier with pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:9 Topics: Acute Disease; Aged; Amino Acids, Branched-Chain; Chemotherapy, Adjuvant; Deoxycytidine; Female; Gemcitabine; Hepatic Encephalopathy; Hepatitis B; Humans; Lactulose; Liver; Pancreatic Neoplasms; Tomography, X-Ray Computed	2010
Rifaximin for the treatment of hepatic encephalopathy. Transplantation proceedings, 2010, Volume: 42, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Transplantation; Male; Middle Aged; Rifamycins; Rifaximin	2010
Treatment of hepatic encephalopathy with rifaximin: more to think about. Hepatology (Baltimore, Md.), 2011, Volume: 53, Issue:3 Topics: Hepatic Encephalopathy; Humans; Lactulose; Rifamycins; Rifaximin	2011
A possible case of minimal hepatic encephalopathy treated successfully with lactulose. The Journal of neuropsychiatry and clinical neurosciences, 2011,Winter, Volume: 23, Issue:1 Topics: Female; Hepatic Encephalopathy; Humans; Incidental Findings; Lactulose; Middle Aged; Treatment Outcome	2011
What is the evidence? Portosystemic shunt in a dog. Journal of the American Veterinary Medical Association, 2011, Apr-01, Volume: 238, Issue:7 Topics: Animals; Anti-Ulcer Agents; Diet; Dog Diseases; Dogs; Evidence-Based Medicine; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Lactulose; Liver Diseases; Male; Omeprazole; Portal System; Stomach Ulcer; Treatment Outcome	2011
Lactulose a day keeps encephalopathy at bay. Journal of gastroenterology and hepatology, 2011, Volume: 26, Issue:6 Topics: Acute Disease; Blood Transfusion; Esophageal and Gastric Varices; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome	2011
Lactulose: how many ways can one drug be prescribed? The American journal of gastroenterology, 2011, Volume: 106, Issue:9 Topics: Constipation; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypernatremia; Lactulose; Male; Middle Aged; Practice Patterns, Physicians'	2011
Linkage of gut microbiome with cognition in hepatic encephalopathy. American journal of physiology. Gastrointestinal and liver physiology, 2012, Jan-01, Volume: 302, Issue:1 Topics: Cognition Disorders; Cytokines; Endotoxins; Feces; Female; Gastrointestinal Agents; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Metagenome; Middle Aged; Rifamycins; Rifaximin; Systems Biology	2012
Durability of rifaximin response in hepatic encephalopathy. Journal of clinical gastroenterology, 2012, Volume: 46, Issue:2 Topics: Adult; Aged; Anti-Infective Agents; Drug Therapy, Combination; End Stage Liver Disease; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Rifamycins; Rifaximin; Severity of Illness Index; Time Factors	2012
Diagnosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatology (Baltimore, Md.), 2012, Volume: 55, Issue:4 Topics: Accidents, Traffic; Aged; Cohort Studies; Cost-Benefit Analysis; Follow-Up Studies; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Markov Chains; Middle Aged; Neuropsychological Tests; Psychometrics; Rifamycins; Rifaximin; Severity of Illness Index; United States	2012
What type of probiotic was used? European journal of gastroenterology & hepatology, 2012, Volume: 24, Issue:4 Topics: Dipeptides; Female; Hepatic Encephalopathy; Humans; Lactulose; Male; Probiotics	2012
A longitudinal systems biology analysis of lactulose withdrawal in hepatic encephalopathy. Metabolic brain disease, 2012, Volume: 27, Issue:2 Topics: Aged; Brain Chemistry; Cytokines; Feces; Gastrointestinal Tract; Hepatic Encephalopathy; Humans; Lactulose; Least-Squares Analysis; Longitudinal Studies; Magnetic Resonance Spectroscopy; Male; Metabolomics; Metagenome; Middle Aged; Neuropsychological Tests; Recurrence; Systems Biology	2012
Reversible laminar signal intensity in deep cortical gray matter in T1-weighted images and FLAIR after mild acute hyperammonemic hepatic encephalopathy. Journal of neuroradiology = Journal de neuroradiologie, 2012, Volume: 39, Issue:5 Topics: Cerebral Cortex; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hyperammonemia; Lactulose; Magnetic Resonance Imaging; Middle Aged; Neurons; Treatment Outcome	2012
Motor vehicle accidents: how should cirrhotic patients be managed? World journal of gastroenterology, 2012, Jun-07, Volume: 18, Issue:21 Topics: Accidents, Traffic; Algorithms; Amino Acids, Branched-Chain; Coffee; Cognition; Cognition Disorders; Fibrosis; Hepatic Encephalopathy; Humans; Lactulose; Neuropsychological Tests; Psychometrics; Risk Factors; Treatment Outcome; Wounds and Injuries; Zinc	2012
Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality. Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:8 Topics: Female; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Primary Prevention	2012
Restricting protein intake not beneficial. Deutsches Arzteblatt international, 2012, Volume: 109, Issue:29-30 Topics: Hepatic Encephalopathy; Humans; Lactulose; Rifamycins	2012
Will health insurers cover the costs? Deutsches Arzteblatt international, 2012, Volume: 109, Issue:29-30 Topics: Hepatic Encephalopathy; Humans; Lactulose; Rifamycins	2012
Status epilepticus as a manifestation of hepatic encephalopathy. Acta neurologica Scandinavica, 2003, Volume: 107, Issue:2 Topics: Acidosis; Anticonvulsants; Electroencephalography; Female; Hepatic Encephalopathy; Hepatitis B; Humans; Hyperammonemia; Hypoxia; Lactulose; Liver Cirrhosis; Middle Aged; Status Epilepticus	2003
[Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis]. Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology, 2002, Issue:5 Topics: Adult; Aged; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Quality of Life	2002
Hepatic encephalopathy: nomenclature, pathogenesis and treatment. Revista espanola de enfermedades digestivas, 2003, Volume: 95, Issue:2 Topics: Anti-Bacterial Agents; Antifungal Agents; Bromocriptine; Dipeptides; Dopamine Agonists; Electroencephalography; Flumazenil; GABA Modulators; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Liver Failure, Acute; Liver Transplantation; Neomycin; Nutritional Physiological Phenomena; Practice Guidelines as Topic; Prognosis; Sodium Benzoate; Terminology as Topic; Time Factors; Zinc	2003
Probiotics can treat hepatic encephalopathy. Medical hypotheses, 2003, Volume: 61, Issue:2 Topics: Ammonia; Anti-Bacterial Agents; Digestive System; Hepatic Encephalopathy; Humans; Lactulose; Models, Biological; Probiotics	2003
[Cirrhotic liver gives up in breaking up of ammonia. Poison for the brain]. MMW Fortschritte der Medizin, 2004, Jan-29, Volume: 146, Issue:5 Topics: Ammonia; Clinical Trials as Topic; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Quality of Life; Self-Help Groups	2004
Treatment of hepatic encephalopathy: it's not lactulose. BMJ (Clinical research ed.), 2004, Jul-10, Volume: 329, Issue:7457 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Randomized Controlled Trials as Topic	2004
Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy. Medical hypotheses, 2005, Volume: 64, Issue:1 Topics: Ammonia; Anti-Bacterial Agents; Clinical Trials as Topic; Hepatic Encephalopathy; Humans; Intestinal Mucosa; Intestines; Lactulose; Models, Biological; Probiotics; Treatment Outcome	2005
Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World journal of gastroenterology, 2005, Feb-14, Volume: 11, Issue:6 Topics: Ammonia; Animals; Endotoxins; Gastrointestinal Agents; Hepatic Encephalopathy; Incidence; Lactulose; Liver; Liver Function Tests; Male; Probiotics; Rats; Rats, Sprague-Dawley; Severity of Illness Index; Thioacetamide	2005
Neostigmine for the treatment of acute hepatic encephalopathy with acute intestinal pseudo-obstruction in a cirrhotic patient. Journal of Korean medical science, 2005, Volume: 20, Issue:1 Topics: Air; Ammonia; Blood Pressure; Cholinesterase Inhibitors; Electrolytes; Enema; Fibrosis; Hepatic Encephalopathy; Humans; Intestinal Pseudo-Obstruction; Lactulose; Liver; Male; Middle Aged; Neostigmine; Peristalsis; Polyethylene Glycols; Radiography; Time Factors	2005
Recovery from parkinson syndrome and prolonged visually evoked potentials in hepatic encephalopathy. Metabolic brain disease, 2005, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Antiparkinson Agents; Benzothiazoles; Brain; Chronic Disease; Dipeptides; Evoked Potentials, Visual; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Parkinsonian Disorders; Paromomycin; Pramipexole; Recovery of Function; Thiazoles; Treatment Outcome; Vision Disorders	2005
[Case of autosomal dominant polycystic kidney disease presenting hepatic encephalopathy]. Nihon Jinzo Gakkai shi, 2005, Volume: 47, Issue:4 Topics: Aged; Cysts; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Diseases; Polycystic Kidney, Autosomal Dominant; Renal Dialysis; Renal Veins; Splenic Vein	2005
Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology (Baltimore, Md.), 2006, Volume: 43, Issue:4 Topics: Adolescent; Adult; Anisotropy; Brain; Brain Edema; Case-Control Studies; Diffusion Magnetic Resonance Imaging; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Treatment Outcome	2006
Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Digestive diseases and sciences, 2007, Volume: 52, Issue:3 Topics: Adult; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Length of Stay; Liver Cirrhosis; Male; Middle Aged; New Jersey; Rifamycins; Rifaximin	2007
Can we ignore minimal hepatic encephalopathy any longer? Hepatology (Baltimore, Md.), 2007, Volume: 45, Issue:3 Topics: Disaccharides; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Incidence; Lactulose; Psychometrics; Quality of Life; Rifamycins; Rifaximin	2007
Transjugular intrahepatic portosystemic shunt prior to cardiac surgery with cardiopulmonary bypass in patients with cirrhosis and portal hypertension. Heart, lung & circulation, 2007, Volume: 16, Issue:6 Topics: Aged; Aortic Valve Stenosis; Cardiac Tamponade; Cardiopulmonary Bypass; Coronary Artery Disease; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portasystemic Shunt, Transjugular Intrahepatic; Postoperative Hemorrhage	2007
Nightly high dose lactulose infusion could be a cost-effective treatment for hepatic encephalopathy, renal insufficiency and heart failure. Medical hypotheses, 2007, Volume: 69, Issue:1 Topics: Cardiac Output, Low; Cost-Benefit Analysis; Drug Administration Schedule; Hepatic Encephalopathy; Humans; Infusions, Intravenous; Lactulose; Renal Insufficiency	2007
Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life. Hepatology (Baltimore, Md.), 2007, Volume: 46, Issue:3 Topics: Gastrointestinal Agents; Gastrointestinal Diseases; Hepatic Encephalopathy; Humans; Lactulose; Prospective Studies; Quality of Life; Syndrome; Treatment Outcome	2007
The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis. Alimentary pharmacology & therapeutics, 2007, Oct-15, Volume: 26, Issue:8 Topics: Cost-Benefit Analysis; Female; Gastrointestinal Agents; Hepatic Encephalopathy; Hospitalization; Humans; Lactulose; Liver Failure; Liver Transplantation; Los Angeles; Male; Middle Aged; Rifamycins; Rifaximin	2007
How to dispel myths in the treatment of hepatic encephalopathy? Nature clinical practice. Gastroenterology & hepatology, 2007, Volume: 4, Issue:10 Topics: Gastrointestinal Agents; Hepatic Encephalopathy; Humans; Lactulose	2007
A 55-year-old man with liver failure, delirium and seizures. Brain pathology (Zurich, Switzerland), 2007, Volume: 17, Issue:4 Topics: Brain; Delirium; Diagnosis, Differential; Fatal Outcome; Gastrointestinal Agents; Granuloma, Giant Cell; Hepatic Encephalopathy; Humans; Kidney; Lactulose; Liver; Liver Cirrhosis; Liver Failure, Acute; Lymph Nodes; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Middle Aged; Multiple Organ Failure; Sarcoidosis; Seizures	2007
[Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy]. Nederlands tijdschrift voor geneeskunde, 2007, Dec-08, Volume: 151, Issue:49 Topics: Adult; Aged; Ammonia; Confusion; Diagnosis, Differential; Electroencephalography; Fatal Outcome; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver; Male; Middle Aged; Treatment Outcome	2007
Hepatic encephalopathy. The Medical clinics of North America, 1981, Volume: 65, Issue:1 Topics: Amino Acids; Ammonia; Bromocriptine; Constipation; Dietary Proteins; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Hypnotics and Sedatives; Infections; Kidney Diseases; Lactulose; Levodopa; Liver Diseases; Neomycin; Neurotransmitter Agents	1981
Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1981, Volume: 64, Issue:12 Topics: Adult; Chronic Disease; Fatal Outcome; Follow-Up Studies; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Treatment Outcome	1981
Spectral analysis of the EEG in hepatic encephalopathy treated with levodopa. Electroencephalography and clinical neurophysiology, 1981, Volume: 52, Issue:6 Topics: Adult; Aged; Electroencephalography; Evoked Potentials; Female; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Neomycin; Pregnancy	1981
[Therapy of hepatic coma]. Deutsche medizinische Wochenschrift (1946), 1984, Mar-30, Volume: 109, Issue:13 Topics: Anti-Bacterial Agents; Bromocriptine; Cimetidine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Liver Transplantation; Magnesium Sulfate; Parenteral Nutrition; Plant Proteins; Plasmapheresis	1984
Portal systemic encephalopathy. The Nurse practitioner, 1984, Volume: 9, Issue:7 Topics: Anti-Bacterial Agents; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose	1984
Portal systemic encephalopathy-sorbitol--a potential replacement for lactulose. The British journal of clinical practice, 1984, Volume: 38, Issue:9 Topics: Hepatic Encephalopathy; Humans; Lactulose; Sorbitol	1984
Lactulose or lactose in hepatic encephalopathy? Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1983, Volume: 2, Issue:1 Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactose; Lactulose	1983
Lactulose-induced hypernatremia. Drug intelligence & clinical pharmacy, 1984, Volume: 18, Issue:1 Topics: Aged; Disaccharides; Drinking; Hepatic Encephalopathy; Humans; Hypernatremia; Lactulose; Male	1984
Hypernatremia and lactulose therapy. JAMA, 1983, Mar-11, Volume: 249, Issue:10 Topics: Creatinine; Diarrhea; Disaccharides; Hepatic Encephalopathy; Humans; Hypernatremia; Lactulose; Liver; Sodium	1983
Lactulose: a crucial element in treating hepatic encephalopathy. Nursing, 1982, Volume: 12, Issue:8 Topics: Disaccharides; Enema; Hepatic Encephalopathy; Humans; Lactulose	1982
Hepatic encephalopathy. The Journal of the Medical Society of New Jersey, 1982, Volume: 79, Issue:12 Topics: Hepatic Encephalopathy; Humans; Lactulose; Neomycin	1982
[Early diagnosis and therapy of hepatic coma in viral hepatitis--theoretical concepts and practical possibilities]. Zeitschrift fur arztliche Fortbildung, 1982, Apr-01, Volume: 76, Issue:7 Topics: Amino Acids; Exchange Transfusion, Whole Blood; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Hypoglycemia; Lactulose; Liver Regeneration; Neomycin; Perfusion; Prednisone; Time Factors	1982
[1st use of lactitol in the treatment of porto-systemic encephalopathy]. Schweizerische medizinische Wochenschrift, 1982, Sep-18, Volume: 112, Issue:38 Topics: Esophageal and Gastric Varices; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Portacaval Shunt, Surgical; Postoperative Complications; Sugar Alcohols	1982
[Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy]. Fortschritte der Medizin, 1982, Nov-25, Volume: 100, Issue:44 Topics: Constipation; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Salmonella Infections	1982
[Main characteristics of the treatment of liver cirrhosis]. Therapie der Gegenwart, 1981, Volume: 120, Issue:5 Topics: Adolescent; Adult; Ascites; Bed Rest; Bloodletting; Child; Child, Preschool; Cholestyramine Resin; Dietary Fats; Dietary Proteins; Diuretics; Energy Intake; Female; Hemochromatosis; Hepatic Encephalopathy; Hepatolenticular Degeneration; Humans; Lactulose; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Penicillamine; Potassium; Vitamin B 12	1981
Portal systemic encephalopathy--should lactulose and neomycin be used together. The British journal of clinical practice, 1981, Volume: 35, Issue:9 Topics: Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Lactulose; Neomycin	1981
[Treatment of hepatic encephalopathy with lactulose]. Medicinski arhiv, 1981, Volume: 35, Issue:5-6 Topics: Adult; Aged; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged	1981
[The effect of lactitol (NS-4) on the concentrations of ammonia and amino acids in blood and cerebrospinal fluid in Eck fistula (portacaval-shunted) dogs]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1995, Volume: 105, Issue:5 Topics: Amino Acids; Ammonia; Animals; Disease Models, Animal; Dogs; Hepatic Encephalopathy; Lactulose; Male; Portacaval Shunt, Surgical; Sugar Alcohols	1995
Sodium benzoate and lactulose for the treatment of hepatic encephalopathy. Journal of hepatology, 1994, Volume: 21, Issue:6 Topics: Animals; Benzoates; Benzoic Acid; Drug Synergism; Hepatic Encephalopathy; Lactulose; Rats; Rats, Wistar	1994
Marked deterioration in glycemic control with change in brand of lactulose syrup. Southern medical journal, 1995, Volume: 88, Issue:4 Topics: Aged; Blood Glucose; Diabetes Mellitus; Drugs, Generic; Hepatic Encephalopathy; Humans; Hyperglycemia; Insulin; Intestinal Absorption; Lactulose; Liver Cirrhosis, Alcoholic; Male; Portasystemic Shunt, Surgical	1995
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors. The American journal of gastroenterology, 1995, Volume: 90, Issue:4 Topics: Adult; Age Distribution; Aged; Cohort Studies; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Incidence; Lactulose; Male; Middle Aged; Multivariate Analysis; Portasystemic Shunt, Surgical; Proportional Hazards Models; Risk Factors; Sex Distribution; Survival Rate	1995
[Lactitol suppresses the disturbance of consciousness caused by experimentally induced hepatic encephalopathy in rats: an EEG study]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1995, Volume: 105, Issue:2 Topics: Animals; Consciousness Disorders; Disease Models, Animal; Electroencephalography; Hepatic Encephalopathy; Humans; Lactulose; Rats; Rats, Wistar; Sugar Alcohols	1995
[Effect of lactitol (NS-4) on the increase in blood and brain ammonia concentration and on coma in newly developed rat models of hepatic coma]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 1995, Volume: 105, Issue:2 Topics: Ammonia; Animals; Brain; Disease Models, Animal; Hepatic Encephalopathy; Lactulose; Male; Rats; Rats, Sprague-Dawley; Sugar Alcohols	1995
[Recent advances in the treatment of decompensated liver cirrhosis]. Nihon rinsho. Japanese journal of clinical medicine, 1994, Volume: 52, Issue:1 Topics: Albumins; Alprostadil; Amino Acids, Branched-Chain; Diuretics; Glucagon; Hepatic Encephalopathy; Humans; Insulin; Jaundice; Lactulose; Liver Cirrhosis	1994
[Lactulose fermentation and lactose absorption in Chilean patients with liver cirrhosis: importance for hepatic encephalopathy therapy]. Revista medica de Chile, 1993, Volume: 121, Issue:5 Topics: Adolescent; Adult; Aged; Case-Control Studies; Child; Chile; Female; Fermentation; Hepatic Encephalopathy; Humans; Hydrogen; Lactose Intolerance; Lactulose; Liver Cirrhosis; Male; Middle Aged	1993
[Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use]. Orvosi hetilap, 1993, Jun-27, Volume: 134, Issue:26 Topics: Cholic Acid; Cholic Acids; Colon; Constipation; Gastrointestinal Transit; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Intestine, Small; Lactulose; Sugar Alcohols	1993
Prevalence of latent portasystemic encephalopathy in an unselected population of patients with liver cirrhosis in general practice. Zeitschrift fur Gastroenterologie, 1993, Volume: 31, Issue:4 Topics: Adult; Aged; Cross-Sectional Studies; Drug Monitoring; Family Practice; Female; Germany; Hepatic Encephalopathy; Humans; Hypertension, Portal; Incidence; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Psychometrics	1993
In vitro and in vivo lactose and lactulose effects on colonic fermentation and portal-systemic encephalopathy parameters. Scandinavian journal of gastroenterology. Supplement, 1997, Volume: 222 Topics: Anti-Bacterial Agents; Colon; Feces; Fermentation; Gastrointestinal Agents; Hepatic Encephalopathy; Humans; In Vitro Techniques; Lactose; Lactose Intolerance; Lactulose; Neomycin	1997
Proton MR spectroscopic measurement of neurometabolites in hepatic encephalopathy during oral lactulose therapy. AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:9 Topics: Administration, Oral; Adult; Brain; Choline; Creatine; Glutamic Acid; Glutamine; Hepatic Encephalopathy; Humans; Lactulose; Magnetic Resonance Spectroscopy; Middle Aged; Reference Values	1998
Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients. The American journal of gastroenterology, 1999, Volume: 94, Issue:8 Topics: Adult; Aged; Ammonia; Female; Helicobacter Infections; Helicobacter pylori; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neuropsychological Tests; Psychometrics	1999
[Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?]. MMW Fortschritte der Medizin, 2000, Jun-22, Volume: 142, Issue:25 Topics: Ammonia; Dipeptides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin	2000
Hepatic Encephalopathy. The American journal of gastroenterology, 2001, Volume: 96, Issue:7 Topics: Adult; Bromocriptine; Dietary Proteins; Digestive System; Flumazenil; Gastrointestinal Agents; Goals; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neurotransmitter Agents; Nitrogen; Splanchnic Circulation; Therapeutic Irrigation	2001
Home lactulose enema: prevention of hepatic encephalopathy at home. Journal of gastroenterology, 2002, Volume: 37, Issue:1 Topics: Enema; Gastrointestinal Agents; Hepatic Encephalopathy; Home Nursing; Humans; Lactulose; Liver Diseases; Male; Middle Aged; Patient Readmission; Self Administration	2002
[Different therapeutic approaches for chronic diffuse liver lesions using ornicetil, lactulose, etimizol and corinfar]. Likars'ka sprava, 2002, Issue:2 Topics: Etimizol; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Middle Aged; Nifedipine; Ornithine; Treatment Outcome	2002
[Lactulose in the treatment of hepatic (pre)coma]. Nederlands tijdschrift voor geneeskunde, 1978, Feb-11, Volume: 122, Issue:6 Topics: Colon; Disaccharides; Drug Combinations; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Neomycin	1978
Lactulose: a drug in search of a modus operandi. Gastroenterology, 1978, Volume: 74, Issue:3 Topics: Ammonia; Colon; Disaccharides; Escherichia coli; Feces; Galactosides; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactobacillus acidophilus; Lactulose	1978
Effect of lactulose, neomycin and antacid on colonic pH recorded continuously with an implanted electrode. The American journal of gastroenterology, 1979, Volume: 72, Issue:2 Topics: Animals; Antacids; Colon; Disaccharides; Electrodes, Implanted; Hepatic Encephalopathy; Hydrogen-Ion Concentration; Lactulose; Male; Neomycin; Rats	1979
[The treatment of hepatic emergencies]. Fortschritte der Medizin, 1979, Feb-01, Volume: 97, Issue:5 Topics: Cimetidine; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Lactulose; Liver Diseases; Male; Parenteral Nutrition; Poisoning; Pregnancy; Pregnancy Complications; Water-Electrolyte Balance	1979
Night sleep organization in patients with severe hepatic failure. Its modifications after L-dopa treatment. European neurology, 1978, Volume: 17, Issue:5 Topics: Adult; Aged; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Male; Middle Aged; Sleep; Sleep Stages; Sleep, REM	1978
The rectal administration of lactulose. Australian and New Zealand journal of medicine, 1975, Volume: 5, Issue:2 Topics: Aged; Ammonia; Colon; Disaccharides; Electroencephalography; Enema; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Male; Middle Aged; Sodium Chloride	1975
Pneumatosis coli following treatment with lactulose. New York state journal of medicine, 1979, Volume: 79, Issue:12 Topics: Adult; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Pneumatosis Cystoides Intestinalis	1979
Emergency treatment of portal-systemic encephalopathy with lactulose enemas. A controlled study. Acta clinica Belgica, 1979, Volume: 34, Issue:3 Topics: Ammonia; Disaccharides; Emergencies; Enema; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male	1979
[Recent acquisitions in the treatment and pathogenesis of hepatic coma]. Recenti progressi in medicina, 1977, Volume: 63, Issue:2 Topics: Adult; Female; Hepatic Encephalopathy; Humans; Infant; Lactulose; Levodopa; Male; Neomycin	1977
The liver: a pharmacologic perspective. The Nursing clinics of North America, 1977, Volume: 12, Issue:2 Topics: Acetaldehyde; Alcoholism; Chemical and Drug Induced Liver Injury; Diuretics; Drug-Related Side Effects and Adverse Reactions; Ethanol; Hepatic Encephalopathy; Humans; Inactivation, Metabolic; Lactulose; Levodopa; Liver; Liver Cirrhosis; Liver Diseases; Microsomes, Liver; Neomycin; Oxidation-Reduction; Pharmaceutical Preparations; Spironolactone; Vasopressins	1977
Hepatic encephalopathy. Arizona medicine, 1977, Volume: 34, Issue:12 Topics: Chronic Disease; Hepatic Encephalopathy; Humans; Lactulose; Neomycin	1977
The use of lactulose in portal-systemic encephalopathy. Connecticut medicine, 1978, Volume: 42, Issue:2 Topics: Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Portal System	1978
[Diagnosis and therapy of hepatic coma]. Godisen zbornik na Medicinskiot fakultet vo Skopje, 1975, Volume: 21 Topics: Hepatic Encephalopathy; Humans; Lactobacillus acidophilus; Lactulose	1975
[Present-day therapy of hepatic encephalopathy (author's transl)]. MMW, Munchener medizinische Wochenschrift, 1976, Dec-24, Volume: 118, Issue:52-53 Topics: Acid-Base Imbalance; Ammonia; Anemia; Anti-Bacterial Agents; Exchange Transfusion, Whole Blood; Glucose; Hepatic Encephalopathy; Humans; Hypoxia; Intestinal Mucosa; Ketoglutaric Acids; Kidney; Lactulose; Liver Cirrhosis; Ornithine; Perfusion; Prognosis; Renal Dialysis	1976
[Clinical picture and therapy of portal-systemic encephalopathy (author's transl)]. Leber, Magen, Darm, 1977, Volume: 7, Issue:4 Topics: Acetates; Acidosis; Alcoholism; Amino Acids; Ammonia; Astrocytes; Dietary Proteins; Diuretics; Hemorrhage; Hepatic Encephalopathy; Humans; Hypokalemia; Lactulose; Liver; Liver Cirrhosis; Neomycin; Potassium; Skin Manifestations; Water-Electrolyte Balance	1977
[Lactulose and portocaval encephalopathy: value of its administration by rectal route]. Medecine & chirurgie digestives, 1977, Volume: 6, Issue:5 Topics: Disaccharides; Hepatic Encephalopathy; Lactulose; Rectum; Therapeutic Irrigation	1977
Lactulose (cephulac) in portosystemic encephalopathy. JAMA, 1976, Nov-22, Volume: 236, Issue:21 Topics: Ammonia; Depression, Chemical; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Recurrence	1976
[Treatment of cirrhotic encephalopathy]. Medecine & chirurgie digestives, 1976, Volume: 5, Issue:3 Topics: Amino Acids; Anti-Bacterial Agents; Dietary Proteins; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	1976
[Pre-intensive treatment in the pre-coma stage of severe viral hepatitis]. La Clinica terapeutica, 1976, May-31, Volume: 77, Issue:4 Topics: Adrenal Cortex Hormones; Adult; Female; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Lactulose; Male; Middle Aged; Vitamin K	1976
Chronic hepatic encephalopathy. The Medical clinics of North America, 1975, Volume: 59, Issue:4 Topics: Amino Acids, Essential; Ammonia; Analgesics; Anesthesia; Anti-Bacterial Agents; Biogenic Amines; Chronic Disease; Constipation; Dietary Proteins; Dihydroxyphenylalanine; Diuretics; Fatty Acids; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Hypnotics and Sedatives; Infections; Lactulose; Methionine; Portacaval Shunt, Surgical; Tranquilizing Agents; Uremia	1975
Acute hepatic failure. The Central African journal of medicine, 1975, Volume: 21, Issue:1 Topics: Acute Disease; Exchange Transfusion, Whole Blood; Hepatic Encephalopathy; Hepatitis A; Humans; Lactulose; Neomycin	1975
[Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment]. Chirurgia e patologia sperimentale, 1975, Volume: 23, Issue:2 Topics: Adult; Aged; Ammonia; Disaccharides; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Portacaval Shunt, Surgical	1975
[Therapy of coma in liver cirrhosis]. La Clinica terapeutica, 1975, Jul-15, Volume: 74, Issue:1 Topics: Adenosine Triphosphate; Ammonia; Arginine; Brain; Colon; Disaccharides; Hepatic Encephalopathy; Humans; Hydroxamic Acids; Intestinal Absorption; Lactulose; Levodopa; Liver Cirrhosis	1975
Hepatic failure and coma after liver resection is reversed by manipulation of gut contents: the role of endotoxin. Surgery, 1991, Volume: 110, Issue:2 Topics: Ammonia; Analysis of Variance; Animals; Cefazolin; Cholestyramine Resin; Endotoxins; Gastrointestinal Contents; Glutamine; Hepatectomy; Hepatic Encephalopathy; Isotonic Solutions; Lactulose; Male; Neomycin; Random Allocation; Rats; Rats, Inbred Strains; Sodium Chloride	1991
First and second generation non absorbable disaccharides in the treatment of hepatic encephalopathy. The Italian journal of gastroenterology, 1990, Volume: 22, Issue:6 Topics: Hepatic Encephalopathy; Humans; Lactose; Lactulose; Sugar Alcohols	1990
Effects of lactulose and lactitol on protein digestion and metabolism in conventional and germ free animal models: relevance of the results to their use in the treatment of portosystemic encephalopathy. Gut, 1990, Volume: 31, Issue:12 Topics: Animals; Digestion; Feces; Germ-Free Life; Hepatic Encephalopathy; Lactulose; Nitrogen; Proteins; Rats; Rats, Inbred Strains; Sugar Alcohols; Swine; Swine, Miniature	1990
[Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy]. Przeglad lekarski, 1990, Volume: 47, Issue:7 Topics: Amino Acids; Amino Acids, Branched-Chain; Ammonia; Brain; Brain Chemistry; Chronic Disease; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Liver	1990
The degradation of amino acids, proteins, and blood to short-chain fatty acids in colon is prevented by lactulose. Gastroenterology, 1990, Volume: 98, Issue:2 Topics: Albumins; Amino Acids; Blood; Colon; Disaccharides; Fatty Acids, Volatile; Feces; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose	1990
Nonabsorbable disaccharides plus neomycin in hepatic encephalopathy: do they enhance each other? Hepatology (Baltimore, Md.), 1990, Volume: 12, Issue:2 Topics: Absorption; Disaccharides; Drug Synergism; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Sugar Alcohols	1990
[Lactulose]. Gastroenterologie clinique et biologique, 1990, Volume: 14, Issue:6-7 Topics: Cell Membrane Permeability; Colon; Colorectal Neoplasms; Constipation; Disaccharides; Gallbladder Diseases; Gastrointestinal Transit; Hepatic Encephalopathy; Humans; Lactulose	1990
Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy. Journal of gastroenterology and hepatology, 1989, Volume: 4 Suppl 1 Topics: Drug Resistance; Feces; Hepatic Encephalopathy; Humans; Lactulose; Vancomycin	1989
Lactulose as an anti-endotoxin in liver transplantation. Lancet (London, England), 1989, Oct-14, Volume: 2, Issue:8668 Topics: Disaccharides; Endotoxins; Hepatic Encephalopathy; Humans; Lactulose; Liver Transplantation	1989
Portal-systemic encephalopathy and hepatic coma. The Medical clinics of North America, 1986, Volume: 70, Issue:5 Topics: Amino Acids; Ammonia; Dietary Proteins; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Neurotransmitter Agents	1986
Lactitol. Lancet (London, England), 1987, Jul-11, Volume: 2, Issue:8550 Topics: Hepatic Encephalopathy; Humans; Lactulose; Sugar Alcohols	1987
Nutritional pharmacology. American family physician, 1985, Volume: 32, Issue:2 Topics: Amino Acids, Branched-Chain; Brain Diseases; Choline; Diet; Dyskinesia, Drug-Induced; Hepatic Encephalopathy; Humans; Huntington Disease; Hypercholesterolemia; Lactulose; Memory Disorders; Phosphatidylcholines; Sitosterols; Synaptic Transmission	1985
[Therapeutic effect of vancomycin hydrochloride, a nonabsorbable antibiotic, on intractable (lactulose resistant) chronic hepatic encephalopathy in cirrhotic patients]. Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1986, Volume: 60, Issue:4 Topics: Aged; Chronic Disease; Drug Resistance; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Male; Middle Aged; Vancomycin	1986
The effect of (a) neomycin and lactulose treatment on systemic and portal serum GABA levels in rats and (b) pH changes on [3H] GABA binding to isolated rat hepatocytes. Clinical and investigative medicine. Medecine clinique et experimentale, 1988, Volume: 11, Issue:5 Topics: Animals; Common Bile Duct; Disaccharides; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Homeostasis; Hydrogen-Ion Concentration; Lactulose; Ligation; Liver; Liver Diseases; Male; Neomycin; Portal Vein; Rats; Rats, Inbred Strains	1988
Lactulose detoxifies in vitro short-chain fatty acid production in colonic contents induced by blood: implications for hepatic coma. Gastroenterology, 1988, Volume: 94, Issue:3 Topics: Bacteria; Blood; Colon; Disaccharides; Fatty Acids, Volatile; Feces; Fermentation; Hepatic Encephalopathy; Humans; In Vitro Techniques; Lactulose; Male	1988
[Treatment of patients with chronic liver diseases with lactulose and bifidum milk. Principles and problems]. Fortschritte der Medizin, 1988, Jun-10, Volume: 106, Issue:17 Topics: Biological Products; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis	1988
In hepatic coma, the problem comes from the colon, but will the answers come from there? The Journal of laboratory and clinical medicine, 1987, Volume: 110, Issue:3 Topics: Ammonia; Bacteria; Colon; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Neomycin; Nitrogen	1987
[Therapy of portosystemic encephalopathy]. La Clinica terapeutica, 1986, May-31, Volume: 117, Issue:4 Topics: Amino Acids, Branched-Chain; Ammonia; Bromocriptine; Dietary Proteins; Hepatic Encephalopathy; Humans; Lactulose; Levodopa; Neomycin	1986
Lactulose and severe lactic acidosis. Annals of internal medicine, 1985, Volume: 103, Issue:4 Topics: Acidosis; Adult; Disaccharides; Hepatic Encephalopathy; Humans; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Lactates; Lactulose; Male; Medullary Sponge Kidney	1985
Lactitol in the treatment of chronic hepatic encephalopathy: an open comparison with lactulose. Gut, 1985, Volume: 26, Issue:4 Topics: Adult; Ammonia; Cerebrovascular Circulation; Chronic Disease; Disaccharides; Electroencephalography; Hepatic Encephalopathy; Humans; Lactulose; Male; Middle Aged; Patient Acceptance of Health Care; Psychological Tests; Sugar Alcohols; Time Factors; Veins	1985
Treatment of an hepatic encephalopathic crisis in a dog. The Veterinary record, 1985, May-18, Volume: 116, Issue:20 Topics: Animals; Dietary Carbohydrates; Dietary Proteins; Disaccharides; Dog Diseases; Dogs; Hepatic Encephalopathy; Lactulose; Male	1985
[Ambulatory diagnosis and therapy control of portasystemic encephalopathy in patients with liver cirrhosis]. Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten, 1985, Volume: 45, Issue:6 Topics: Aged; Ammonia; Female; Hepatic Encephalopathy; Humans; Hypertension, Portal; Lactulose; Liver Cirrhosis; Male; Middle Aged; Neomycin; Neuropsychological Tests; Psychomotor Performance; Reaction Time; Tremor	1985
[Lactulose in the treatment of chronic portosystemic encephalopathies]. Ceskoslovenska gastroenterologie a vyziva, 1974, Volume: 28, Issue:3 Topics: Adult; Aged; Chronic Disease; Disaccharides; Electroencephalography; Female; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Liver Diseases; Male; Mental Disorders; Middle Aged; Nervous System Diseases	1974
Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose. Digestion, 1974, Volume: 10, Issue:6 Topics: Ammonia; Blood Urea Nitrogen; Brain Diseases; Chlorides; Chronic Disease; Disaccharides; Drug Therapy, Combination; Hepatic Encephalopathy; Humans; Hydrogen-Ion Concentration; Lactulose; Liver Cirrhosis; Liver Function Tests; Neomycin; Potassium; Sodium	1974
The effect of lactulose on the faecal flora of patients with hepatic encephalopathy. Journal of medical microbiology, 1974, Volume: 7, Issue:2 Topics: Bacteria; Bacteriological Techniques; Bacteroides; Cell Count; Clostridium; Computers; Diet Therapy; Dietary Proteins; Disaccharides; Escherichia coli; Feces; Female; Hepatic Encephalopathy; Humans; Lactobacillus; Lactulose; Magnesium Sulfate; Male; Species Specificity; Streptococcus	1974
Lactulose in the treatment of acute hepatic encephalopathy. The American journal of the medical sciences, 1973, Volume: 266, Issue:2 Topics: Acute Disease; Ammonia; Connecticut; Dietary Proteins; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Neomycin; Nitrogen	1973
[Lactulose in the therapy of porto-systemic encephalopathy]. Minerva medica, 1973, Dec-05, Volume: 64, Issue:87 Topics: Adult; Aged; Brain Diseases; Disaccharides; Hepatic Encephalopathy; Humans; Lactulose; Liver Cirrhosis; Middle Aged	1973
[Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy]. Revista espanola de las enfermedades del aparato digestivo, 1974, Feb-01, Volume: 42, Issue:3 Topics: Administration, Oral; Animals; Disaccharides; Evaluation Studies as Topic; Hepatic Encephalopathy; Humans; Lactulose; Male; Neomycin	1974
Milk protein in the treatment of chronic portasystemic encephalopathy. A long-term study of therapeutic measures in a patient with chronic porta-systemic encephalopathy. The Netherlands journal of medicine, 1974, Volume: 17, Issue:2 Topics: Aged; Ammonia; Animals; Chronic Disease; Diet Therapy; Dogs; Electroencephalography; Hepatic Encephalopathy; Humans; Lactose; Lactulose; Male; Milk Proteins; Neomycin; Portal System	1974